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A B S T R A C T
Background
Specialised disease management programmes for chronic heart failure (CHF) improve survival, quality of life and reduce healthcare
utilisation. The overall efficacy of structured telephone support or telemonitoring as an individual component of a CHF disease
management strategy remains inconclusive.
Objectives
To review randomised controlled trials (RCTs) of structured telephone support or telemonitoring compared to standard practice for
patients with CHF in order to quantify the effects of these interventions over and above usual care for these patients.
Search strategy
Databases (the Cochrane Central Register of Controlled Trials (CENTRAL), Database of Abstracts of Reviews of Effects (DARE)
and Health Technology Assessment Database (HTA) on The Cochrane Library,MEDLINE, EMBASE, CINAHL, AMED and Science
Citation Index Expanded and Conference Citation Index on ISI Web of Knowledge) and various search engines were searched from
2006 to November 2008 to update a previously published non-Cochrane review. Bibliographies of relevant studies and systematic
reviews and abstract conference proceedings were handsearched. No language limits were applied.
Selection criteria
Only peer reviewed, published RCTs comparing structured telephone support or telemonitoring to usual care of CHF patients were
included. Unpublished abstract data was included in sensitivity analyses. The intervention or usual care could not include a home visit
or more than the usual (four to six weeks) clinic follow-up.
Data collection and analysis
Data were presented as risk ratio (RR) with 95% confidence intervals (CI). Primary outcomes included all-cause mortality, all-cause
and CHF-related hospitalisations which were meta-analysed using fixed effects models. Other outcomes included length of stay, quality
of life, acceptability and cost and these were described and tabulated.
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Main results
Twenty-five studies and five published abstracts were included. Of the 25 full peer-reviewed studies meta-analysed, 16 evaluated
structured telephone support (5613 participants), 11 evaluated telemonitoring (2710 participants), and two tested both interventions
(included in counts). Telemonitoring reduced all-cause mortality (RR 0.66, 95%CI 0.54 to 0.81, P < 0.0001) with structured telephone
support demonstrating a non-significant positive effect (RR 0.88, 95% CI 0.76 to 1.01, P = 0.08). Both structured telephone support
(RR 0.77, 95% CI 0.68 to 0.87, P < 0.0001) and telemonitoring (RR 0.79, 95% CI 0.67 to 0.94, P = 0.008) reduced CHF-related
hospitalisations. For both interventions, several studies improved quality of life, reduced healthcare costs and were acceptable to patients.
Improvements in prescribing, patient knowledge and self-care, andNewYorkHeart Association (NYHA) functional class were observed.
Authors’ conclusions
Structured telephone support and telemonitoring are effective in reducing the risk of all-causemortality andCHF-related hospitalisations
in patients with CHF; they improve quality of life, reduce costs, and evidence-based prescribing.
P L A I N L A N G U A G E S U M M A R Y
Structured telephone support and telemonitoring in the management of patients with chronic heart failure
In the context of limited health funding, and a rapidly expanding population of older patients with chronic heart failure (CHF) it is
increasingly difficult for healthcare systems to provide high-quality care to patients with CHF. Multi-disciplinary specialist heart failure
clinics are available only to a minority of patients and do not have the capacity for frequent patient review. Patients may be unwilling
or unable to make frequent clinic attendance due to financial, transport or disability constraints. Structured telephone support and
telemonitoring can provide specialised heart failure care to a large number of patients with limited access to healthcare services. This
review demonstrates that CHF interventions utilising information technology can reduce the rates of death and hospitalisation and
improve the quality of life. The majority of elderly patients learned to use the technology easily and were satisfied with receiving
healthcare in this way.
B A C K G R O U N D
The efficacy of structured telephone support or telemonitoring as
a successful individual component of a heart failure programme
remains inconclusive. Whether there are independent and mea-
surable benefits of structured telephone support or telemonitoring
for patients with chronic heart failure is the focus of this review.
Description of the condition
Chronic heart failure (CHF) is a complex, debilitating syndrome
due to cardiac dysfunction that impairs the ability of the ventricle
to fill with, or eject, blood. As a result, typical symptoms such
as dyspnoea and fatigue occur at rest or with reduced physical
effort. CHF often results from damage to the myocardium for
which the aetiology differs according to the population studied.
In high income nations CHF is often the end-product of under-
lying coronary heart disease (Cowie 1997). In low to medium
income nations the syndrome is often the result of longstanding
hypertension, cardiomyopathy or rheumatic heart disease (Sliwa
2005). This trend is changing, with the incidence and prevalence
of atherosclerotic disease increasing in low to medium income na-
tions (Yusuf 2001). CHF exerts a substantial burden on health-
care systems, due to the high consumption of human resources
caused predominantly by repeated and lengthy admissions to hos-
pital (Stewart 2002).
As the prevalence of CHF increases with the ageing of populations
internationally, it will become increasingly difficult tomaintain the
quality of care. Switching resources from crisis management (by
hospitalising patients) to health maintenance (through structured
telephone support or home telemonitoring) may be an affordable
method to maintain and improve the quality of care for CHF.
Trials of pharmacological treatments, including ACE inhibitors,
beta-blockers, aldosterone antagonists and, to some extent, an-
giotensin receptor blockers, and of devices such as implantable
defibrillators and cardiac re-synchronisation therapy have demon-
strated that these therapies can improve the prognosis of patients
with stable heart failure who have a reduced left ventricular ejec-
tion fraction (LVEF) (Krum 2009). Recent trials have indicated
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an annual mortality of 3% or less for younger patients with mild
symptoms with an implanted defibrillator (Moss 2009), about 7%
amongst older patients with few implanted devices (GISSI-HF
2008) and about 12% for those withmoderate or severe symptoms
(Kjekshus 2007). Rates of hospitalisation for worsening heart fail-
ure are generally similar, although perhaps proportionately higher
in those who have a defibrillator. Fewer trials have been conducted
in patients with heart failure who do not have a marked reduction
in LVEF and none have been conclusively positive (Cleland 2006).
These trials suggest an annual mortality of 4% to 5% and, again, a
similar rate of hospitalisation for worsening heart failure (Cleland
2006; Massie 2008). The lack of success of recent pharmacologi-
cal interventions in altering the outcome of acute heart failure is
well reported (Konstam 2007; McMurray 2007; Mebazaa 2007).
These trials suggest a six month mortality of 15% to 30% and
high rates of readmission. Most trials of telemonitoring have fo-
cused on patients being discharged after an exacerbation of heart
failure in patients with a low LVEF (Clark 2007a; Cleland 2005
(Telemon)) and have shown a high mortality in patients assigned
to usual care which is consistent with the above.
Surveys and epidemiological data provide, at first sight, a gloomier
picture (Jhund 2009; Levy 2002). This may reflect the exclusion
from research trials of sicker patients by some investigators on
compassionate grounds, a lower likelihood that older and sicker
patients will agree to research or exclusion by protocols of patients
with co-morbidities that carry an adverse prognosis (Cleland 2007;
Jhund 2009; Lenzen 2005). Also, patients in trials are likely to be
much more closely monitored and this may have had a favourable
influence on prognosis, consistent with the evidence from trials of
telemonitoring. However, perhaps themost important reason why
patients in surveys have an outcome similar to those with acute
heart failure is because that is the point at which most patients in
surveys of heart failure are enrolled (Cleland 2001). About 20% of
patients will die in the first year of new-onset heart failure (Harjola
2010; Jhund 2009; Levy 2002). The mortality one year after an
acute exacerbation of chronic heart failure is about 30% (Harjola
2010) but much worse in older patients. In contrast to clinical
trials, left ventricular ejection fraction does not appear to be a
major determinant of prognosis, possibly because the inclusion
of older patients with multiple co-morbidities has an over-riding
effect (Bhatia 2006; Cleland 2007).
Description of the intervention
The effectiveness of multidisciplinary approaches to manage pa-
tients with CHF has been demonstrated by meta-analyses, such
as those conducted by McAlister (McAlister 2004) and special-
ist CHF disease management programmes are now recommended
in best practice guidelines (ESC Heart Failure Guidelines 2008;
Hunt 2005; Krum 2006). To date, trials of specialist, multi-
disciplinary CHF management programmes have tested multi-
faceted approaches (multidisciplinary input, home/clinic visits,
telephone support). As a consequence, it has been difficult to iden-
tify the incremental benefits of the components of each inter-
vention (McAlister 2004; Yu 2006). Nevertheless, it is clear that
within most populations access to these programmes is limited as
a result of barriers related to funding or accessibility (Clark 2005;
Jaarsma 2006).
To meet the needs of CHF populations who have difficulty ac-
cessing multidisciplinary CHF disease management programmes,
alternative models of care have been proposed and tested (these
alternative models typically involve information communication
technology and may include self-monitoring and education de-
livered via standard telephone or more advanced telemonitoring
technology (e.g. electronic transfer of physiological data - elec-
trocardiograph (ECG), blood pressure (BP), weight, pulse oxime-
try, respiratory rate and medicine administration) (Clark 2007a)
(Figure 1 and Figure 2).
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Figure 1. Structured telephone support
4Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 2. Example of telemonitoring
In this report, we a priori classified programmes as being “struc-
tured telephone support” if the monitoring and/or self-care man-
agement was delivered using simple telephone technology (data
may have been collected and stored by a computer) and “telemon-
itoring” if there was digital/broadband/satellite/wireless or blue-
tooth transmission of physiologic and other non-invasive data
(Figure 1 and Figure 2).
We consider that structured telephone support and telemonitor-
ing are two similar but distinctly different interventions, as such
we have reported outcomes for each intervention separately rather
than as either telemonitoring or structured telephone support. It
should be noted that in the context of this review the term “remote
monitoring” refers to the use of these technologies (structured
telephone support or telemonitoring) outside of a CHF specialist
centre of care and not necessarily remote in the geographical sense.
Most studies have been conducted in urban or semi-rural popu-
lations in regions with high population densities. In all studies of
structured telephone support, having access to a touch-tone tele-
phone was an essential inclusion criteria. Participants from socioe-
conomically disadvantaged groups may have been excluded if they
did not have access to a touch-tone telephone. In the case of tele-
monitoring the information communication technology equip-
ment and monitoring devices were provided by the project regard-
less of socioeconomic status.
Why it is important to do this review
In this era of rapidly advancing and wider community access and
adaptation to information technology, new trials of remote mon-
itoring interventions have been continually commissioned and
published. Earlier systematic reviews and meta-analyses (Clark
2007a; Louis 2003;McAlister 2004) examined the benefits of tele-
monitoring and/or structured telephone support within CHF dis-
ease management programmes on mortality and hospitalisation,
however several important large multi-national trials of remote
monitoring interventions have since been published.
Although the most recent review of remote monitoring by Clark
and colleagues reported beneficial effects on all-cause mortality in
14 trials (Clark 2007a), results for all-cause hospitalisations and
HF-specific hospitalisations were inconclusive due to small num-
bers of events. A number of systematic reviews on this topic have
since been published (Chaudry 2007; Dang 2009; DelliFraine
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2008; Gaikward 2009; Klersy 2009) and have examined the im-
pact of remote patient monitoring versus usual care. As opposed to
this analysis, the systematic review and meta-analysis undertaken
by Klersy included interventions employing home visits, frequent
visits to CHF specialist clinics, and invasive monitoring under
their definition of “remote monitoring” (Klersy 2009).
Given the burgeoning evidence base on this topic and the inter-
ests of European Society of Cardiology and the American Heart
Association heart failure guideline committees, we felt an updated
systematic review incorporating recent evidence was appropriate
at this time. Our main aim was to review the efficacy of structured
telephone support and telemonitoring as stand-alone components
of multidisciplinary CHF management.
O B J E C T I V E S
The objective of this study is to update the systematic review and
meta-analysis previously completed by Clark 2007a and system-
atically assess the effects of telemonitoring and/or structured tele-
phone support programmes on:
1. All-cause mortality, CHF-related admission to hospital, all-
cause readmissions to hospital and;
2. Length of stay, quality of life, healthcare cost savings in
patients with CHF and acceptability of the intervention to
patients with CHF.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) comparingCHF
management delivered via structured telephone support or tele-
monitoring with usual post-discharge care in patients with CHF
living within the community. We included RCTs which have been
published in the peer-reviewed literature; we also identified ab-
stracts that met our inclusion criteria and these were used to per-
form sensitivity analyses. We excluded any studies that did not re-
port data for our outcomes of interest in an extractable format (we
contacted authors of each primary study in an attempt to get all
the data that is possible before excluding any study on this basis).
Types of participants
Adults (aged≥ 18 years) of either sex, any age or ethnic group with
definitive a diagnosis of CHF. Patients may have been recently dis-
charged from an acute care setting (including emergency depart-
ments and one-day-stay procedures) to home (including a rela-
tive’s home but excluding nursing homes or convalescence homes)
or they may have been recruited to a study while managed in the
community setting. Studies dealing with general cardiac disorders
rather than specifically with CHF were excluded.
Types of interventions
Structured telephone support or telemonitoring interventions
needed to be structured as opposed to offering telephone follow-
up on an “as needed” basis. They must have been initiated by a
healthcare professional (medical, nursing, social work, pharmacist)
and delivered to patients with CHF living in the community as
the only aftercare intervention, without home visits or intensified
clinic follow-up. They had to be targeted towards the patient, and
intended to address the patient’s concerns and problems, not those
of caregivers. The patient must not have been visited at home by
a specialised CHF healthcare professional or study personnel for
the purpose of education or clinical assessment other than an ini-
tiation visit to set-up equipment. Usual care consisted of standard
post-discharge care without intensified attendance at cardiology
clinics or clinic-based CHF disease management programme or
home visiting as described above.
Types of outcome measures
Primary outcomes
• All-cause mortality (total number of deaths at the end of
study follow-up in each arm of the study).
Secondary outcomes
• All-cause hospitalisations (calculated as the proportion of
patients readmitted to hospital at least once during the period of
follow-up).
• CHF-related hospitalisations (calculated as the proportion
of patients readmitted to hospital at least once during the period
of follow-up due to CHF).
• Length of stay.
• Health-related quality of life (difference between mean total
score on validated measures such as Minnesota Living with Heart
Failure Questionnaire between baseline and at study conclusion
for the intervention and control groups).
• Cost of the intervention and cost effectiveness (reported
cost of the intervention; reported difference in the cost of
medical care during the course of the study between the
intervention and control groups).
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• Acceptability of the intervention to patients.
Search methods for identification of studies
This reviewupdates a previously published reviewwhich examined
the period January 1966 to 6 May 2006 (Clark 2007a) and as
such, all databases were searched from 2006 onwards. Language
restrictions did not apply to any of the searches.
Electronic searches
We searched the following databases:
1. Cochrane Central Register of Controlled Trials
(CENTRAL), Database of Abstracts of Reviews of Effects
(DARE) and Health Technology Assessment Database (HTA) on
The Cochrane Library (Issue 4, 2008).
2. MEDLINE (2006 to 21 November 2008).
3. EMBASE (2006 to 21 November 2008).
4. CINAHL (2006 to 27 November 2008).
5. AMED (2006 to 21 November 2008).
6. Science Citation Index Expanded and Conference Citation
Index on ISI Web of Knowledge (2006 to 21 November 2008).
The search strategies are listed in Appendix 1.
Searching other resources
We also searched the following resources (“heart failure” and tele*
/ “cardiac failure” and tele*):
1. National Research Register (NRR) Archive https://
portal.nihr.ac.uk/Pages/NRRArchive.aspx (28 November 2008
and 19 December 2008).
2. Google Scholar (limited to the first 500 identified hits due
to the large volume of information this resource contains) (27
November 2008 and 5 December 2008).
3. IEEE Xplore (26 November 2008 and 5 December 2008).
4. OAIster (27 November 2008 and 5 December 2008).
5. Informit http://www.informit.com.au/ (28 November
2008 and 19 December 2008).
6. Vivisimo/Clusty http://clusty.com/ (28 November 2008
and 19 December 2008).
7. Australian Digital Theses Program (28 November 2008 and
19 December 2008).
8. Proquest Digital Dissertations (28 November 2008 and 19
December 2008).
Bibliographies of identified studies and published systematic re-
views relevant to this topic area were hand searched. Abstracts and
conference proceedings from the following international confer-
ences were handsearched for relevant studies:
1. European Society of Cardiology Congress (2006, 2007,
2008).
2. American College of Cardiology Congress (2006, 2007,
2008).
3. American Heart Association (2006, 2007, 2008).
4. Heart Failure Society of America (2006, 2007, 2007).
5. European Society of Cardiology Heart Failure Congress
(2006, 2007, 2008).
6. World Congress of Cardiology (2006, 2008).
7. Asia Pacific Heart Failure Congress (2008).
8. European Society of Cardiology Annual Spring Meeting of
Cardiovascular Nursing (2006, 2007, 2008).
Data collection and analysis
All identified abstracts and results from database searches were
reviewed by SCI and RAC for relevance to the review topic. If the
reference appeared to be relevant, a full copy of the reference was
obtained for detailed review to determine the inclusion/exclusion
of the study in the review.
Selection of studies
Two investigators (SCI and RAC) independently reviewed the
results of each search according to exclusion and inclusion criteria.
Studies were excluded if home visits were performed as part of the
intervention or by the clinical staff involved in the intervention or
if there were clinic visits (more than usual care) offered to patients
in the intervention or control groups. A third reviewer (JGFC)
adjudicated in the instance of disagreement between the first two
reviewers.
Data extraction and management
Two reviewers (SCI and RAC) abstracted the data from the in-
cluded studies in a blinded manner and all extracted data was
checked by a third reviewer (FAM).
Assessment of risk of bias in included studies
In consideration of Cochrane methodology (Higgins 2008a),
study quality and risk of bias was assessed independently by two
reviewers (SCI and RAC).The study quality characteristics and
bias assessment were rated as ’unclear’ (not stated), yes (low risk
of bias) and no (high risk of bias) with examples from the text to
support this classification.
Inclusion criteria of the included participants
The definition and confirmation of diagnosis of CHF.
• ’Yes’ i.e. low risk of bias - a diagnosis of CHF (systolic or
preserved) recorded and confirmed using clinical criteria,
echocardiography, or BNP
• ’No’ i.e. high risk of bias - diagnosis of CHF not defined
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Generation of the randomisation sequence
• ’Yes’ i.e. low risk of bias - random permuted blocks, random
computer generated, sealed assignment, sequentially numbered
sealed opaque envelopes
• ’No’ i.e. high risk of bias - case record numbers, date of
birth or days of the week
Allocation concealment
• ’Yes’ i.e. low risk of bias - allocation to each group
performed adequately and group assignment revealed after
provision of consent
• ’No’ i.e. high risk of bias - group assignment revealed prior
to subject consent, non-opaque sealed envelopes, case record
numbers, date of birth or day of the week
Baseline comparability of the groups
• ’Yes’ i.e. low risk of bias - the baseline characteristics of each
study group (in particular age, NYHA Class and/or LVEF) is
clearly outlined and any differences identified are accounted for.
• ’No’ i.e. high risk of bias - baseline characteristics (in
particular age, NYHA Class and/or LVEF) of each study group
are not outlined.
Blinding
Focused on outcomes assessors and data analysts, it is not con-
sidered plausible that patients could be blinded to these types of
interventions.
• ’Yes’ i.e. low risk of bias - independent outcome assessors
and data analysts who are blinded to which group the patient
belongs to.
• ’No’ i.e. high risk of bias - outcomes assessed and data
analysed by those involved in the intervention, or those who are
aware of group membership.
Completeness of follow-up
• ’Yes’ i.e. low risk of bias - proportion and characteristics of
those participants lost to follow-up clearly reported for each
group and outcome. A clear outline is provided as to how losses
of participants were handled.
• ’No’ i.e. high risk of bias - proportion and characteristics of
those completing and not completing the study according to
group and outcome not reported. No statement regarding how
losses to follow up were accounted for in the study analysis.
Statistical power
• ’Yes’ i.e. low risk of bias - a power calculation was
performed and reported. The study was adequately powered to
detect differences in outcomes.
• ’No’ i.e. high risk of bias - a power calculation was not
performed. A power calculation was performed and reported but
the study was not adequately powered to detect differences in
outcomes. A power calculation was performed but not reported,
the study states it was adequately powered to detect differences in
outcomes.
Risk of bias (selection, performance, detection and attrition)
Risk of bias was identified for each included study and tabulated
according to the following headings.
• Type of bias
• Definition of the type of bias relevant to these types of
studies and interventions
• Example from text suggesting a possible source of bias
• Comment on how this potential source of bias may have
influenced the study outcomes
• Overall judgement on the importance of this identified
potential source of bias on study quality and validity
Measures of treatment effect
Datawere dichotomous and the statisticalmethodused for analysis
was Mantel-Haenzel with an analysis model for fixed effects (
Higgins 2008b). Risk ratios and 95% confidence intervals were
calculated for all-cause mortality, and proportions of patients with
at least one all-cause and HF-related hospitalisation. All analyses
were performed according using intention-to-treat analysis, that
is, all patients and their outcomes were analysed in the groups to
which they were allocated, regardless of whether they received the
treatment or whether or not they were measured for the outcome.
Studieswhichmeasured outcomes such as quality of life using tools
such as the Minnesota Living with Heart Failure Questionnaire
were tabulated and described. Due to inconsistency in reporting of
length of stay, this outcome was tabulated also rather than pooled
in a meta-analysis.
Assessment of heterogeneity
Statistical heterogeneity in each outcome of interest was examined
using chi-squared test and I² statistic as stated in the Cochrane
Handbook (Higgins 2008b).
Data synthesis
Owing to differences in patient populations, programme charac-
teristics, and length of follow-up, all meta-analyses were performed
using fixed effects model.
8Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sensitivity analysis
Two sensitivity analyses were performed. Our search identified
five studies that were only published in abstract form (Angermann
2007; Blum 2007 (MCCD); Krum 2009 (CHAT); Parati 2009
(ICAROS); Zugck 2008 (HiTel)). According to advice from the
Cochrane Heart Group we did not include data from these studies
in the principal meta-analyses due to the likelihood of these results
being interim results or without having undergone extensive peer
review to confirm the results and assess the rigor of the study
methodology (McAlister 2006).Data from these studieswas added
todata from studieswhichwere published in the formof a full peer-
reviewed journal publication to assess whether publication status
made any difference to the result of the meta-analyses, including
the level of heterogeneity.
The second sensitivity analysis was performed to assess the impact
of length of follow-up on outcomes. We excluded studies with
a follow-up period of six months or less from these sensitivity
analyses. This was performed for full peer-reviewed publications
only.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies.
Searching the databases and search engines has retrieved a total of
8033 results:
• CENTRAL, DARE, HTA 324
• MEDLINE 254
• EMBASE 205
• CINAHL 52
• AMED 15
• ISI 318
• NRR 2854 and 2331
• Google Scholar 500 and 500
• IEEE Xplore 312 and 11
• OAIster 76 and 2
• Informit 3 and 3
• Vivisimo/Clusty 135 and 110
• Australian Digital Theses Program 2 and 2
• Proquest 6 and 18
324 references were excluded as duplicates. Handsearching of con-
ference abstracts retrieved 243 references. 7663 references out of
the remaining 7952 references were excluded in the initial screen-
ing process. 289 references were identified to be potentially rele-
vant. Handsearching the bibliographies of these studies identified
additional 33 references.
Overall, 322 references were identified as potentially relevant stud-
ies and full copies of these references were retrieved for assessment
according to our inclusion and exclusion criteria. The majority of
the studies (n = 245) were excluded as they were not RCTs (n =
95), other reasons for exclusion included the intervention or usual
care involving home or clinic visits (n = 57); the reference was a
review or editorial (n = 28); the participants did not have heart
failure (n = 11); the intervention was invasive monitoring (n = 11)
or because the research was other types of heart failure research,
for example, education or exercise programmes (n = 37) or the
outcomes of interest were not measured in the study (n = 5) or
the intervention was not compared to usual care (n = 1). A study
flowchart details these exclusions (Figure 3).
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Figure 3. Study flowchart
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In total we have included 16 studies of structured telephone sup-
port (two were published abstracts: Angermann 2007, Krum2009
(CHAT)), 12 studies of telemonitoring (three of which were pub-
lished abstracts: Blum 2007 (MCCD), Parati 2009 (ICAROS),
Zugck 2008 (HiTel)) and two studies with both structured tele-
phone support and telemonitoring intervention arms (compared
to usual care). Only studies which were published in full peer-re-
viewed journals were included in the primary meta-analysis. Stud-
ies published only in abstract form were included in a sensitivity
meta-analysis for the primary outcomes of interest in this review.
Therefore, the primarymeta-analysis included 25 studies, 16 com-
parisons of structured telephone support to usual care (n = 5613
participants) and 11 comparisons of telemonitoring versus usual
care (n = 2710 participants). This includes data from the two stud-
ies with three arms, which are Cleland 2005(Struct Tele), Cleland
2005 (Telemon), Mortara 2009 (Struct Tele) and Mortara 2009
(Telemon) (245 participants in total in the control arms of these
two studies with both intervention arms) the data from these
studies has been separated into our two interventions of inter-
est (structured telephone support and telemonitoring). Wakefield
2008 included two intervention arms, one using standard tele-
phone equipment and the other a videophone, for the purposes
of our analyses, these two intervention arms were combined and
classed as structured telephone support.
We identified three studies which are currently ongoing (Chaudry
2007 (Tele-HF); Kohler 2006; Kulshreshtha 2008a).
We have identified four studies which are awaiting classifica-
tion pending future publications to clarify details on the in-
terventions or outcomes measured (Dunlap 2006 (HearT-I);
Levine2006(MindMyHeart); Scherr 2005 (MobiTEL); Yakushin
2006).
For the studies included in the primary meta-analysis of the pri-
mary outcomes of interest:
• Trials ranged in size from very large (1518 patients in the
GESICA 2005 (DIAL) Trial) in structured telephone support to
small (34 patients in Barth 2001) and in telemonitoring 502
patients (Kielblock 2007) to 10 (de Lusignan 2001).
• The total numbers of patients rejected from trials for not
being eligible (lack of access to telephone, being of different
ethnic origin unable to understand language etc) was not
reported.
• Mean age of the participants ranged from 44.5 to 78 years.
• Mean percent male participants was 64%, which ranged
from (35% to 99% of participants in included studies being
male). Only four out of the 30 included studies recruited more
women than men (DeWalt 2006; Riegel 2002; Riegel 2006;
Soran 2008).
• Fourteen (47%) of the studies reviewed originated from the
USA; four (13%) Italy; three (10%) Germany; two (7%)
Canada; two (7%) European Union (Germany, Netherlands,
UK, Poland, Italy), one UK; one Netherlands; one India; one
Argentina and one from Australia.
• Fourteen (47%) of the studies reported lost to follow-up.
The mean percent of loss to follow-up was 7.6% (range 0% to
26%).
• Ethnic groups: Riegel 2006 examined the effect of
structured telephone support on a Hispanic population; Soran
2008 included older minorities (elderly women and non-white
males).
• Length of follow-up of these trials ranged from three to 18
months, with many studies reporting outcomes after 12 months.
• Most of the included studies included participants with
symptomatic heart failure, although the definition and inclusion
criteria differed amongst the studies, with some studies reporting
few details of the diagnostic criteria for heart failure.
Studies included in the primary meta-analysis of the primary out-
comes of interest funded by Industry (reported in publications):
1. Balk 2008 Motiva-Phillips
2. Cleland 2005(Struct Tele) - Phillips
3. de Lusignan 2001 - Nexan Telemed Ltd, Cambridge
4. DeWalt 2006 - Pfizer Inc
5. GESICA 2005 (DIAL) - Roche, Boehringer Ingelheim,
Bago. Pharmacia, Novartis, Merck Sharp & Dohme
6. Riegel 2002 - Pfizer Inc
7. Tsuyuki 2004 - Park Davis Canada (Pfizer Canada)
Twenty-eight of the 30 included studies reported outcomes such as
quality of life, cost of the intervention or cost-effectiveness, length
of stay, adherence or participant acceptability of the intervention.
Risk of bias in included studies
Analysis of the distribution in the funnel plots shown in Figure
4, Figure 5, Figure 6, Figure 7, Figure 8 and Figure 9 demon-
strate a strong publication bias towards positive outcomes in the
studies selected for this review. The risk of bias analysis due to
methodological issues (the definition and confirmation of diag-
nosis of CHF; generation of the randomisation sequence; alloca-
tion concealment; baseline comparability of the groups; blinding;
completeness of follow up; statistical power; risk of bias (selection,
performance, detection and attrition)) is presented in Figure 10
and Figure 11. This analysis demonstrated low risk of bias for all
criteria in 30%to60%of studies. Areas with the highest risk of bias
were; adequate power (20%); comparability of groups at baseline
(30%) and reporting of results according to CONSORT guide-
lines (30%) (CONSORT2001) particularly reporting of numbers
and reasons for lost to follow-up. The RCT evidence included in
this review is also summarised and graded in Figure 12, Figure 13
and Figure 14.
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Figure 4. Funnel plot of comparison 1 - impact of structured telephone support and telemonitoring in CHF
on all-cause mortality, analysis 1.1: all-cause mortality (full peer-reviewed publications only): structured
telephone support versus usual care
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Figure 5. Funnel plot of comparison 1 - impact of structured telephone support and telemonitoring in CHF
on all-cause mortality, analysis 1.2: all-cause mortality (full peer-reviewed publications only): telemonitoring
versus usual care
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Figure 6. Funnel plot of comparison 2 - impact of structured telephone or telemonitoring in CHF on risk of
all-cause hospitalisation, analysis 2.1: all-cause hospitalisation (full peer-reviewed publications only): structured
telephone support versus usual care
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Figure 7. Funnel plot of comparison 2 - impact of structured telephone or telemonitoring in CHF on risk of
all-cause hospitalisation, analysis 2.2: all-cause hospitalisation (full peer-reviewed publications only):
telemonitoring versus usual care
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Figure 8. Funnel plot of comparison 3 - impact of structured telephone support or telemonitoring in CHF
on risk of CHF-related hospitalisation rate, analysis 3.1: CHF-related hospitalisation (full peer-reviewed
publications only): structured telephone support versus usual care
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Figure 9. Funnel plot of comparison 3 - impact of structured telephone support or telemonitoring in CHF
on risk of CHF-related hospitalisation rate, analysis 3.2: CHF-related hospitalisation (full peer-reviewed
publications only): telemonitoring versus usual care
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Figure 10. Risk of bias summary: review authors’ judgements about each methodological quality item for
each included study.
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Figure 11. Risk of bias graph: review authors’ judgements about each methodological quality item
presented as percentages across all included studies.
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Figure 12. Summary of findings for all-cause mortality
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Figure 13. Summary of findings for all-cause hospitalisation
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Figure 14. Summary of findings for CHF-related hospitalisations
Overall the heterogeneity ranged from low to substantial across the
primary meta-analysis of the three outcomes of interest (I² statistic
Low = 0%-40%; Moderate = 30%-60%; Substantial = 50%-90%,
Considerable 75%-100%) (Higgins 2008b).
• All-cause mortality (full peer-reviewed publications only):
◦ Structured telephone support vs Usual Care:
Heterogeneity: Chi² = 8.48, df = 13 (P = 0.81); I² = 0%
◦ Telemonitoring vs Usual Care: Heterogeneity: Chi² =
8.84, df = 10 (P = 0.55); I² = 0%
• All-cause hospitalisation (full peer-reviewed publications
only):
◦ Structured telephone support vs Usual Care:
Heterogeneity: Chi² = 13.09, df = 10 (P = 0.22); I² = 24%
◦ Telemonitoring vs Usual Care: Heterogeneity: Chi² =
31.30, df = 7 (P < 0.0001); I² = 78%
• CHF-related hospitalisation (full peer-reviewed
publications only):
◦ Structured telephone support vs. Usual Care:
Heterogeneity: Chi² = 11.84, df = 11 (P = 0.38); I² = 7%
◦ Telemonitoring vs Usual Care: Heterogeneity: Chi² =
4.88, df = 3 (P = 0.18); I² = 39%
Effects of interventions
All-cause mortality
All-cause mortality data were available for 15 peer-reviewed stud-
ies comparing structured telephone support with usual care and 11
studies comparing telemonitoring with usual care (Analysis 1.1;
Analysis 1.2). Telemonitoring was effective in reducing the risk
of all-cause mortality in patients with CHF (telemonitoring RR
0.66, 95% CI 0.54 to 0.81, P < 0.0001, I² 0%), as was structured
telephone support, but this effect size was not statistically signifi-
cant on the risk of all-cause mortality (RR 0.88, 95% CI 0.76 to
1.01, P = 0.08, I² 0%).
Adding five studies (two on structured telephone support (
Angermann 2007; Krum 2009 (CHAT); three on telemonitor-
ing (Blum 2007 (MCCD); Parati 2009 (ICAROS); Zugck 2008
(HiTel)) which were not full peer-reviewed publications to the
meta-analysis decreased the effect of structured telephone support
(RR 0.96, 95% CI 0.84 to 1.09, P = 0.51, I² 16%) (Analysis 1.3).
Only minimal change in the effect of telemonitoring on all-cause
mortality was observedwith the addition of these three studies (RR
0.68, 95% CI 0.57 to 0.82, I² = 0%, P < 0.0001; Analysis 1.4).
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Statistical heterogeneity increased for structured telephone sup-
port (I² 0% to 16%) with the addition of two studies of structured
telephone support (Angermann 2007; Krum 2009 (CHAT)), for
telemonitoring no change was observed (Analysis 1.3; Analysis
1.4).
Sensitivity analyses, performed to explore the influence of length
of follow-up greater than six months on all-cause mortality only
minimally decreased the effect of telemonitoring (RR 0.69, 95%
CI 0.55 to 0.86, P = 0.0009, I² 0%) on all-cause mortality but
did not effect the outcome of structured telephone support on all-
cause mortality (Analysis 1.5; Analysis 1.6).
All-cause hospitalisation
All-cause hospitalisation datawere available for 11 studies compar-
ing structured telephone support with usual care and eight studies
comparing telemonitoring with usual care (Analysis 2.1; Analysis
2.2). Structured telephone support was effective in reducing the
risk of all-cause hospitalisation in patients with CHF (RR 0.92,
95% CI 0.85 to 0.99, P = 0.02, I² 24%), as was telemonitoring
(RR 0.91, 95 CI 0.84 to 0.99, P = 0.02, I² 78%).
With the addition of one study of structured telephone support
published as an abstract only (Krum 2009 (CHAT)), the effect of
this intervention on all-cause hospitalisation in patients with CHF
increased minimally (RR 0.90, 95% 0.84 to 0.97, P = 0.003, I² =
32%; Analysis 2.3). Three telemonitoring studies published only
as abstracts were added for a sensitivity analysis to examine the
influence of peer-reviewed publication on reported all-cause hos-
pitalisation rates (Blum 2007 (MCCD); Parati 2009 (ICAROS);
Zugck 2008 (HiTel)). This altered the results (Analysis 2.4) (RR
0.94, 95% CI 0.87 to 1.01, P = 0.09, I² = 73%).
Sensitivity analyses performed to explore the influence of length
of follow-up greater than six months on all-cause hospitalisation
found that the effect of structured telephone support was slightly
decreased (P = 0.03) however, the effect of telemonitoring in-
creased when the period of follow-up was greater than six months
(RR 0.87, 95% 0.80 to 0.95, P = 0.002, I² = 85%) (Analysis 2.5;
Analysis 2.6).
CHF-related hospitalisation
CHF-related hospitalisation outcomes were available for 13 struc-
tured telephone support studies and four telemonitoring studies
(Analysis 3.1; Analysis 3.2). Both types of interventions were ef-
fective in reducing the proportion of patients with a CHF-related
hospitalisation (structured telephone support RR 0.77, 95% CI
0.68 to 0.87, P < 0.0001, I² = 7% and telemonitoring RR 0.79,
95% CI 0.67 to 0.94, P = 0.008, I² = 39%).
One structured telephone support study published as an abstract
(Krum 2009 (CHAT)) and two telemonitoring studies (Parati
2009 (ICAROS); Zugck 2008 (HiTel)) published as abstracts were
added for sensitivity analyses. Addition of this structured tele-
phone support study did not alter the effect observed on CHF-
related hospitalisations with this intervention, except for decreas-
ing statistical heterogeneity (0%). However, addition of these two
telemonitoring studies improved the effect observed on the CHF-
related hospitalisation outcome favourably, and decreased statisti-
cal heterogeneity (RR 0.76, 95% CI 0.64 to 0.89, P = 0.0006; I²
= 34%) (Analysis 3.3; Analysis 3.4).
The effect of both interventions on CHF-related hospitalisations
were similar to the primarymeta-analyses when sensitivity analyses
were performed to explore the influence of length of follow-up
greater than six months on CHF-related hospitalisations (Analysis
3.5; Analysis 3.6).
Length of stay
Of the 16 studies reporting on structured telephone support ver-
sus usual care, six studies reported length of stay data (Galbreath
2004; Laramee 2003; Riegel 2002; Riegel 2006; Tsuyuki 2004;
Wakefield 2008). Only the study by Tsuyuki 2004 reported a sta-
tistically significant reduction in length of stay in hospital (Table
1). One telemonitoring study, Parati 2009 (ICAROS) reported a
large difference in the total number of days in hospital per pa-
tient, but this was not an analysis of length of stay per hospitalisa-
tion. Zugck 2008 (HiTel) reported a positive trend towards shorter
length of stay for participants in the telemonitoring group, but
this result was not statistically significant. Studies which assessed
both telemonitoring and structured telephone support (Cleland
2005(Struct Tele); Mortara 2009 (Struct Tele)) reported no signif-
icant difference in length of stay for hospital admissions between
groups.
Table 1. Duration of follow-up, Length of Stay, QOL, Cost, Adherence, Acceptability and all other outcome measures
Study
(year)
Endpoint Hospital
Length of Stay
Health and
Quality of Life*
Effect on
Cost /case
Cost of the
Intervention
Acceptability of
Intervention
to Patients and
“Other”
Measures
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Table 1. Duration of follow-up, Length of Stay, QOL, Cost, Adherence, Acceptability and all other outcome measures
(Continued)
Both
Structured Tele-
phone Support
and Telemoni-
toring
Cleland et al.
(2005)
TEN-HMS
Study
QoL Outcomes
report
Louis A et al
(2006)
240 days
400 days
LOS for heart
failure hospitali-
sations (240
days)
(Median IQR)
UC=11 ( 6-20)
NTS =15 (7-29)
HTM=11(6-19)
- - - Overall patient
acceptance was
good at 91.2%.
96% of patients
were well satis-
fied with the sys-
tem and 97%
found the tele-
care devices easy
to use.
4.1% of patients
refused to accept
the technology
in their homes
while 2.9% of
pa-
tients asked for
the equipment to
be removed and
1.8% discontin-
ued recording.
Mortara et al.
(2009)
HHH Study
11.6 months
(mean)
Over the
12 month fol-
low-up
Total
days in hospital
for HF, UC 584
days (1.0%) vs.
HT 1175 Days
(1.1%), HT1
477 (1.2%),
HT2 374(1.2%)
, HT3 324
(1.0%)
NS in reducing
bed days
- - - Pa-
tients completed
81% of all prac-
ticable vital signs
transmissions
from home.
Overall, 92% of
practi-
cable recordings
were carried out
by the patients,
confirming high
feasibility.
Structured Tele-
phone Support
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Table 1. Duration of follow-up, Length of Stay, QOL, Cost, Adherence, Acceptability and all other outcome measures
(Continued)
Angermann et al.
(2007)
INH Study
6 months - SF-36
Age and sex
adjusted physical
functioning (P =
0.036) and phys-
ical health (P =
0.03)
- - Improved
NYHA
Classification (P
= 0.029)
Barth (2001) 2 months - MLCHF§ (P =
0.0005)
- US $23.60/ pa-
tient
-
DeBusk et al.
(2004)
12 months -
-
- - -
DeWalt et al.
(2006)
12 months - Modified
MLCHF§ to ac-
count for all lit-
eracy levels (NS)
S-TOFHLA
(NS)
- - HF Knowledge
Improved (P =
0.001)
Self Efficacy im-
proved 2 points
(P = 0.0026)
Self-care
behaviour
improved (P <
0.001)
Galbreath et al.
(2004)
Cost effectiveness
report
Smith B. et al
(2008)
18 months No statisti-
cal changes for in
patient bed days
between groups
P value for group
effect 0.899
P value for time
effect 0.117
- NS difference in
total healthcare
costs
- 6 minute walk
test (NS)
LVEF (NS)
NYHA function
class (P < 0.001)
Evidence based
pharmacother-
apy (P = 0.002)
Gattis et al.
(1999)
PHARM Study
6 months Not reported - - - Intervention
group closer to
target ACEI dose
(P < 0.001)
GESICA Inves-
tigators
(2005)
DIAL Trial
16 months
(mean)
- Improved
MLCHF§
Mean total score,
intervention vs.
control 30.6 vs.
35.0, mean dif-
fer-
- - In-
creased evidence
based phar-
macotherapy for
CHF
Increase in di-
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Table 1. Duration of follow-up, Length of Stay, QOL, Cost, Adherence, Acceptability and all other outcome measures
(Continued)
ence =4.4, 95%
confidence inter-
val 1.8 to 6.9, P
= 0.001
etary compliance
Krum 2009
CHAT Study
Clark et al.
(2007)
12 months ˙ - - - Adherence
65.8%
Adaptation 97%
Participants
rated the CHAT
project with a to-
tal acceptability
rate of 76.45%
Laramee et al.
(2003)
3 months LOS Inter-
vention vs Con-
trol Mean (SD)
6.9 (6.5) vs. 9.5
(9.8), P = 0.15
- Reduc-
tion US $2482/
patient (average)
US $228.52/ pa-
tient (average)
Adherence
to treatment (
DailyWeighs) (P
< 0.01)
Adherence to
medications (P =
0.04)
Satisfaction (P <
0.01)
patients tak-
ing target doses
of ACEI and BB
Rainville (1999) 12 months - - - - -
Ramachandran
et al.
(2007)
6 months Not reported KCCQ (P <
0.05)
Cost saving
INR 14,592 per
patient annually
- Improvement in
NYHAFunction
class (P = 0.004)
Improvement in
6 minute walk
test (P < 0.02)
Slightly higher
ACEi/ARB dose
in intervention
group at study
end (P < 0.05)
There was a feel-
ing of self-con-
trol that the pa-
tients in the in-
tervention group
acquired
through the pro-
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Table 1. Duration of follow-up, Length of Stay, QOL, Cost, Adherence, Acceptability and all other outcome measures
(Continued)
gramme. Addi-
tion-
ally, there was a
feeling of accessi-
bility to a strong
support system.
Riegel et al.
(2002)
6 months HF
Hospital days (6
months) Inter-
vention vs. Con-
trol Mean (SD)
1.1(3.1) vs. 2.1
(4.6) P = 0.05
(with covariate)
All cause days (6
months) Inter-
vention vs. Con-
trol Mean (SD)
3.5 (6.6) 4.8
(8.3)
P = 0.23 (with
covariate)
- 46% reduction
in inpatient costs
(P = 0.04)
$US443 / pa-
tient
“Patient sat-
isfaction was sig-
nificantly higher
among
persons assigned
to the interven-
tion group than
among
those assigned to
the usual-
care group.” (P =
0.01)
Riegel et al.
(2006)
6 months HF
Hospital days (6
months) Inter-
vention vs. Con-
trol Mean (SD,
95% CI)
3.40(7.1, CI
1.6-5.2) vs. 3.65
(7.8, 1.9-5.4)
NS
MLCHF§, EQ-
5D (NS)
NS difference in
HF cost of care
or all-cause hos-
pital costs
- Depression (NS)
Sisk et al. (2006)
Qol and Cost
Effectiveness re-
ported by Her-
bert (2008)
12 months - Com-
pared with UC,
intervention
patients reported
better function-
ing on both SF-
12 (phys-
ical component
score) (39.9 vs.
36.3, dif-
ference 3.6 [CI
1.2 to 6.1] and
MLCHF§ (38.6
vs. 47.3, differ-
A nurse -led dis-
ease
management
program for pa-
tients with heart
failure improved
quality of life at
an expected cost
to society of un-
der $25,000 per
QALY gained.
The intervention
cost $2177
per patient were
more than offset
by reduced hos-
pital costs
($2378 per pa-
tient) but higher
costs for outpa-
tient procedures,
medications, and
home health care
prevented the in-
-
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ence -8.8 [CI -
15.3 to -2.2])
tervention from
being cost-sav-
ing over the 12-
month study.
Tsuyuki et al.
(2004)
6 months Cardiovascular
Hospital days (6
months) Inter-
vention vs. UC
Mean (SD)
6.4 (6.0) vs. 11.6
(10.3) P = 0.003
Total days 341
vs. 812 P = 0.003
All cause days (6
months) Inter-
vention vs. UC
Total days
627 vs.1082 P =
0.001
- $CAD2531 per
patient
reduction
- -
Wakefield et al.
(2008)
12 months Therewas no sig-
nificant
differences in the
mean number of
hospital days be-
tween groups.
MLCHF§ (in all
groups P =
0.0002)
Mean HF-
related readmis-
sion costs 86%
and
84% lower in the
videophone and
telephone
groups, respec-
tively, compared
to UC
- Satisfaction be-
tween video and
telephone (NS)
Nurse percep-
tions on the dif-
ference in inter-
actions between
video and tele-
phone (NS)
Telemonitoring
Antonicelli et al.
(2008)
12 months - SF-36 (NS)
Ex-
cept for reported
health per-
ception in inter-
vention group, P
< 0.046)
- - -
Balk et al. (2007) 288 days (mean) Total days in
hospital
Intervention vs.
SF-36,
Dutch version of
MLCHF§ (NS)
NS differ-
ence but a trend
towards a reduc-
Increase in costs
in the Interven-
tion group. No
Dutch Knowl-
edge Score (P <
0.001)
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Control
759 (0-116) vs.
762(0-132)
Mean 7.4 vs. 7.9
P value not re-
ported.
tion in contacts
with health pro-
fes-
sionals in inter-
vention group.
decrease in
healthcare costs
in the interven-
tion group, but
the cost
of the telemoni-
toring system in-
creased the total
costs in the inter-
vention group.
“Acceptance
of the guidance
system was high.
The ease of use
was rated very
good or good by
80% of users.
70% mentioned
access to doctors
and nurses was
better”.
Blum et al 2007 794 days (2
years)
Not reported Scores with the
ML-
wHF§ improved
(P = 0.001)
SF36
Mental com-
posite and Phys-
ical composites
improved (P =
0.001 & P =
0.003)
- Not yet available BNP renal Func-
tion and weight
showed signifi-
cant improve-
ments over time
(P =.011, 0.001
% 0.003)
Capomolla
(2004)
12 months - - - - -
de Lusignan et al.
(2001)
12 months - ‡CHFSQ
(NS¶)
+GHQ
- - Video link over
standard tele-
phone lines was
not found to be
useful
by the patients in
the study.
Giordano et al.
(2008)
12 months - - 35% re-
duction in mean
cost for readmis-
sion in interven-
tion group (843
EUR compared
to 1298 EUR in
UC group, P <
0.01)
Daily cost per
patient of inter-
vention was 0.65
EUR and mean
annual cost per
patient was 185
EUR
-
Goldberg et al.
(2003)
WHARF Trial
6 months
(mean)
- MLCHF§, SF-
12, HDS. All
scores were im-
- - Compliance
with the moni-
toring system in
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proved but were
not statistically
significant
theAlereNet arm
was 98.5%
Kielblock et al.
(2007)
and Blasius
(2008)
12 months - - Hospital care ex-
pen-
ditures for treat-
ment group were
45% lower (P =
0.01) but med-
ication expendi-
ture was 15%
higher (NS)
. Overall, health
care costs were
39.5% lower
(6.800 EUR /pa-
tient/ yr) in treat-
ment group (P =
0.05)
Reduction
in hospital costs
of 7128 EUR
per patient (P =
0.01), but an in-
crease in drug ex-
penditure of 245
EUR per patient
(NS).
Highest cost in
death group
The satis-
faction survey re-
vealed that 57%
of those surveyed
considered
the programme
to be “very good”
and 43% “quite
good”. None
of those surveyed
responded with
“not so good” or
“not at all”.
Increased com-
pliance in taking
medicines
Improvement
in NYHA Func-
tional Class
Parati (2008) 6 months Intervention vs.
UC
214 (6.29 days
per patient) vs.
701 (15.57 days
per patient)
- - - -
Soran et al.
(2008)
6 months HF
Hospital days (6
months) Inter-
vention vs. Con-
trol Mean (SD)
9.3(12.2)
vs. 10.0(7.3) P =
0.22
SF-12, KCCQ
(NS)
- - Compliance
97%
Woodend et al.
(2003)
12 months Intervention pa-
tients spent 7.13
vs. 6.71
days (control pa-
tients) in hospi-
tal in 1 year.
Improved
MLCHF§ (P =
0.025)
SF 36 -Improved
(P < 0.05)
Patients receiv-
ing telemonitor-
ing consistently
reported
- - Overall patients
found the equip-
ment easy to use.
Obtaining ECG
most difficult.
Satisfaction was
calculated on the
sum of scores
of 10 questions.
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higher levels of
treatment satis-
faction. Increase
exertional capac-
ity
The mean scores
were 92-97=very
highly satisfied
Zugck et al.
(2008)
HiTel Trial
12 months Significant
reduced in dura-
tion in hospitali-
sation both com-
par-
ing telemedicine
(UCT+HCT)
vs. UC Mean
(SD) 1.5 (4.2) vs.
5.1(7.7) days P =
0.05
- - - -
1 Euro = approx $CAD 1.55 $US1.46 £UK0.09 $Aust 1.60 68.3 INR (In-
dian Rupee)
*Health related quality of life, variance between baseline and study endpoint, details provided as included in study; ‡CHFSQ, Chronic
Heart Failure Symptomatology Questionnaire;+ General Health Questionnaire GHQ § MLCHF, Minnesota Living with Heart
Failure Questionnaire; KCCQ, Kansas City Cardiomyopathy Questionnaire; SF-12, Short Form 12 Item; SF-36, Short Form 36
Item; HDS, Health Distress Score; NS, not statistically significant; Patient acceptability measured at 400 days. Blank cells indicate
no data available for variable. 95% CI = 95% Confidence Intervals.
Quality of life
Quality of Life (QoL) was a secondary outcome for 15 of the 30
included studies. Several different psychometric tools were used
for evaluation (Chronic Heart Failure Symptomatology Ques-
tionnaire (CHFSQ); Minnesota Living with Heart Failure Ques-
tionnaire (MLCHF);KansasCityCardiomyopathyQuestionnaire
(KCCQ); Short Form 12 Item (SF-12); Short Form 36 Item (SF-
36); Health Distress Score (HDS)). Six of the studies in the struc-
tured telephone support versus usual care group reported statis-
tical improvements in QoL in all areas of assessment of physical
and mental health. Seven of the telemonitoring studies reported
QoL, with three telemonitoring studies reporting statistically sig-
nificant improvements in QoL outcomes. Using a similar mixture
of tools as for the structured telephone group areas ofQoL particu-
larly significant were higher levels of treatment satisfaction, higher
levels of health perception, improved physical composite scores
and mental composite scores (Table 1). Studies which assessed
both telemonitoring and structured telephone support (Cleland
2005(Struct Tele); Cleland2005 (Telemon);Mortara 2009 (Struct
Tele);Mortara 2009 (Telemon)) have not reportedQoLoutcomes.
Cost
Twelve studies presented detailed cost analysis for these two
types of technologies (structured telephone support (Barth 2001;
Galbreath 2004; Laramee 2003; Ramachandran 2007; Riegel
2002; Riegel 2006; Sisk 2006; Tsuyuki 2004;Wakefield 2008; and
telemonitoring (Balk 2008; Giordano 2009; Kielblock 2007)).
Cost of the intervention varied according to intensity and tech-
nologies used in the intervention (Table 1). Studies which reported
cost reduction in the cost of care per admission or overall cost
reduction due to reduction in hospitalisation reported cost sav-
ings ranging between 35% and 86%. Reductions were reported
31Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
in all studies which measured economic benefit except Balk 2008,
Galbreath 2004 and Riegel 2006 where no reduction or increases
in cost were reported.
Adherence, adaptation, satisfaction and other
outcomes
Adherance (compliance) was 65.8% (Clark 2007b; Krum
2009 (CHAT)), 97% Soran 2008 and 98.5% (Goldberg 2003
(WHARF)) for structured telephone support and telemonitor-
ing respectively. Adaptation to the technology (Clark 2007b,
Cleland 2005(Struct Tele); Cleland 2005 (Telemon); Krum 2009
(CHAT); Mortara 2009 (Struct Tele); Mortara 2009 (Telemon))
rated at 96% to 97% with few elderly patients unable to learn
to use the technology (Table 1). Satisfaction of patients receiving
health care via technology was rated between 57% to 97%.
Other measures evaluated as outcomes for these trials included
(Table 1):
i) Improved NYHA Functional Class (Angermann 2007;
Galbreath 2004; Kielblock 2007; Ramachandran 2007)
ii) Improved heart failure knowledge and self-care
behaviour (Balk 2008; DeWalt 2006)
iii) Improved six minute walk test (Galbreath 2004;
Ramachandran 2007)
iv) Improved evidence based pharmacotherapy (Galbreath
2004; Gattis 1999 (PHARM); GESICA 2005 (DIAL), Laramee
2003, Kielblock 2007, Ramachandran 2007)
v) Improved BNP (Blum 2007 (MCCD))
D I S C U S S I O N
This review has demonstrated that structured telephone support
and telemonitoring programmes for patients with CHF living in
the community reduce the risk of all-cause mortality by 12% and
more than one third respectively, reduce the risk of CHF hospitali-
sation bymore than one fifth andmay reduce all-cause hospitalisa-
tions 8% to 9%. It provides further confirmation of the efficacy of
structured telephone support or telemonitoring as a component of
contemporary multidisciplinary heart failure management since
our previous systematic review and meta-analysis (Clark 2007a)
on this topic.
While inclusion of the more recently published trials has served
to refine the point estimates for these outcomes we reported in
our earlier meta-analyses, in the case of all-cause and CHF hos-
pitalisations inclusion of the new data has refined the confidence
intervals sufficiently that the results are now statistically signifi-
cant with both interventions. We have also expanded on prior ev-
idence in this field by demonstrating that the results for the risk
of CHF hospitalisation are robust to the inclusion of unpublished
data and for all-cause hospitalisations the benefits are greater in
longer-term studies than those only following patients for shorter
time frames. Despite decreasing the proportion of patients hospi-
talised, less impact was observed on the number of days spent in
hospital. Not only were benefits on mortality and hospitalisation
observed, a statistically significant impact was seen on quality of
life with these interventions.
Since completing our previous review of these interventions,
(Clark 2007a), we identified 16 new studies, comprising of
seven studies of structured telephone support (Angermann
2007; DeWalt 2006; Galbreath 2004; Krum 2009 (CHAT);
Ramachandran 2007; Sisk 2006; Wakefield 2008), eight stud-
ies of telemonitoring (Antonicelli 2008; Balk 2008; Blum
2007 (MCCD); Giordano 2009; Kielblock 2007; Parati 2009
(ICAROS); Soran 2008; Zugck 2008 (HiTel)) and one study
with both a telemonitoring and structured telephone support arm
(Mortara 2009 (Struct Tele)). Of these new included studies, two
structured telephone support studies (Angermann 2007; Krum
2009 (CHAT)) and three telemonitoring studies (Blum 2007
(MCCD); Parati 2009 (ICAROS); Zugck 2008 (HiTel)) are cur-
rently published as abstracts only and were excluded from the
principal meta-analysis and data were only included in sensitivity
analyses.
Structured telephone support and telemonitoring reduced health-
care costs, were acceptable to patients, improved prescribing of
evidence-based pharmacotherapies, improved patient heart failure
knowledge and self care behaviours, and even improved NYHA
functional class in those studies that assessed it.
The first RCTs of structured telephone support or telemonitor-
ing (compared to usual care, without home or clinic visits) were
published in 1999 (Gattis 1999 (PHARM); Rainville 1999). In
the past decade, information technology has progressed rapidly
alongside the need and demand for chronic disease management
for conditions such as CHF. Our previous review, published in
2007 included only 14 RCTs of structured telephone support or
telemonitoring (Clark 2007a). This review documents evidence
from 30 RCTs of these technologies. In light of this exponential
increase inRCTevidence for such interventions in the past decade,
and the ever expanding population of patients with CHF these
findings are important for future healthcare service planning.
Recently published studies of structured telephone support and
telemonitoring programmes have includedmuch longer follow-up
on outcomes, with most of the outcomes from studies included in
this review reported at 12months follow-up or longer. In addition,
several systematic reviews and meta-analyses have been published
on this topic since 2007 (Chaudry 2007; Dang 2009; DelliFraine
2008; Gaikward 2009; Klersy 2009, Maric 2009). Although su-
perficially the recently published reviews appear similar, there are
important differences in inclusion criteria to this review, and par-
ticularly the inclusion of home visits or invasive haemodynamic
monitoring in their definitions of ’remotemonitoring’. Our review
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focused solely on non-invasive monitoring and telephone support
and, as such, we believe is more relevant for health care service
planning in resource-poor environments where access to invasive
monitoring or specially trained staff to conduct home visits is not
an option.
Differences in the inclusion criteria of the recently publishedmeta-
analyses on this topic impairs the ability to directly compare our
findings with the findings of previous meta-analyses. However, a
critical review of these other reports with our findings highlights
the uniqueness and importance of our findings. Klersy and col-
leagues (Klersy 2009) included 20 RCTs and 12 cohort studies of
’remote monitoring’, many of the interventions of the included
studies involved home visits and studies of invasive haemodynamic
monitoring were also included. The 20 RCTs demonstrated a sig-
nificant reduction in the risk of all-cause mortality (RR 0.83, 95%
0.73 to 0.95: P = 0.006) similar, but smaller than what we have re-
ported here. The reduction in the risk of all-cause hospitalisations
was similar, though less thanwhat we have reported, a larger reduc-
tion in heart failure-related hospitalisations was reported by Klersy
(RR 0.71, 95% CI 0.64 to 0.80) (Klersy 2009). The review and
meta-analysis by Klersy did not consider other outcomes such as
quality of life, functional capacity or length of stay (Klersy 2009).
Another recently completed systematic review by Dang and col-
leagues (Dang 2009) synthesised nine RCTs of telemonitoring in
CHF some of which included home visits, concluding that “more
data are needed to determine the ideal patient population, tech-
nology and parameters, frequency and duration of telemonitor-
ing...”. Maric and colleagues (Maric 2009) completed a systematic
review of telemonitoring technologies in heart failure, including
56 studies (not all RCTs) of interventions such as external devices,
telephone support, video consultation, web site based telemoni-
toring. The systematic reviews by Gaikward (Gaikward 2009) and
DelliFraine (DelliFraine 2008) were not specific to heart failure.
Our findings are broadly consistent with those of a review (Yu
2006) that explored which components of CHF Disease Manage-
ment Programs (DMPs) were most effective. The authors of that
review reported that an effective DMP should be multi-faceted
and consists of an in-hospital phase of care, intensive patient edu-
cation, self-care supportive strategy, optimisation’s of medical reg-
imen, and ongoing surveillance and management of clinical de-
terioration. The cardiac nurse and cardiologist should be actively
involved. A flexible approach should be adopted to deliver the fol-
low-up care and Yu 2006 concluded that the characteristics of the
care team and the organisation content and delivery method of
the DMP were crucial to enhance the discharge outcomes of older
people with heart failure.
Although a reduction in the proportion of participants with an
all-cause or CHF-related hospitalisation was observed, we did not
identify a consistent impact of structured telephone support or
telemonitoring on length of stay for such admissions. Length of
stay was inconsistently reported, thus preventing meta-analysis of
this outcome. It is reasonable to suppose that while remote mon-
itoring interventions would prevent episodes of hospitalisation
through early detection and management of clinical deterioration,
inmore serious episodes of decompensation, hospitalisationwould
still be necessary and it cannot be expected that community-based
interventions such as structured telephone support or telemoni-
toring would impact on the care administered in hospital.
We performed two sensitivity analyses to investigate the effects
of publication and length of follow-up on outcomes and hetero-
geneity. Only five studies were not available as full, peer-reviewed
publications and were not included in the primary meta-analyses.
Addition of these studies to our meta-analyses did not significantly
alter our findings and in most instances statistical heterogeneity
increased. Little difference was seen when meta-analyses were lim-
ited to studies with a follow-up longer than six months with some
increases to heterogeneity observed. The two structured telephone
support studies and three telemonitoring studies which were only
available as abstracts reported similar effects to those studies which
were published as full-peer reviewed publications across the three
outcomes of interest which were meta-analysed.
Of the three outcomes included in our meta-analysis, the greatest
heterogeneity was observed for all-cause hospitalisations for tele-
monitoring studies (I² =78%). One study with the least number
of participants (Antonicelli 2008) reported a substantially lower
proportion of patients in the intervention arm (telemonitoring)
hospitalised for all-causes over the follow-up period and this dif-
ference may account for some of the heterogeneity observed for
this outcome. The methodological reasons for this difference in
reported outcomes for this particular study is unclear, but may
relate to the intervention and the clinical management of these
patients. There are no obvious differences in the study participants
or study methodology that can be identified to account for this
difference.
Jaarsma (Jaarsma 2008) has indicated that intensified intervention
in heart failure management does not necessarily produce greater
benefits on a composite endpoint of death or heart failure-related
hospitalisation regardless of strategy. This then suggests that the
key issue for heart failure management becomes one of cost ef-
fectiveness, and that is likely to be determined by the number of
staff required to support a heart failure management intervention
(as the major cost of healthcare in developed society is human
resource expenditure).
This review is novel in that we sought to delineate the bene-
fits of one form of CHF disease management on patient out-
comes while controlling for other disease management interven-
tions which may confound the benefits of structured telephone
support and telemonitoring. It is important to consider the ben-
efits that these sole interventions can deliver as there are some
circumstances where such interventions may be the only option
for providing specialised CHF management. However, structured
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telephone support and telemonitoring (and many other forms
of technology delivered heart failure programmes) are now con-
sidered to be standard interventions within the multidisciplinary
model of heart failuremanagement (ESCHeart Failure Guidelines
2008).
Krumholz and colleagues (Krumholz 2006) have outlined a tax-
onomy for disease management which encourages authors to de-
scribe their study intervention under eight domains. These eight
domains include: 1) Patient population; 2) Intervention recipi-
ent; 3) Intervention content; 4) Delivery personnel; 5) Method
of communication; 6) Intensity and complexity; 7) Environment
and 8) Clinical outcomes (Krumholz 2006).We found that the in-
cluded studies inconsistently reported these details which in turn
did not allow us to explore differences in these domains as poten-
tial explanations for any observed heterogeneity between studies.
Many of the included studies were published prior to publication
of the taxonomy, but future reports of such interventions should
be clearly described under these headings. Similarly,Clark and col-
leagues (Clark 2009) have called for a more specific evidence base
to support the development of effective programmes for different
populations. They have called for future reviews to pool data by
sex or age, however, we were unable to do so in this review as very
few of the included studies presented outcomes in a manner that
permitted these data to be extracted. We have, however identified
that for most of the studies men were predominately recruited
rather than women. We were also unable to pool outcomes based
on age of the participants. An individual patient data meta-anal-
ysis would be the best method to stratify outcomes according to
important demographic and clinical variables, such as sex, age,
cardiac function and co-morbidities.
A major limitation to the studies conducted so far is that the
research study is conducted in parallel to the existing service on
patients who are willing to participate in research and by staff
that are usually super-numerate to the service that delivers routine
clinical care. This division between research study and clinical
service is likely to make home monitoring less efficient and less
effective.Moreover, without a service how can health professionals
get experience and training in how to make home monitoring
work? Ideally, studies should integrate home monitoring into the
routine service. However, until home monitoring, in particular
telemonitoring is adopted as a service this is exceedingly difficult.
The nature of the control group should be considered with care
when interpreting clinical trials of home telemonitoring. It is likely
that marked intensification of more conventional methods of de-
livering care, such as more home or clinic visits, can deliver results
similar to those of home telemonitoring. This may account for
the neutral outcome observed in some studies (Cleland 2009; Dar
2009 (HOME-HF)). However, employing health professionals is
the by far the largest part of health care costs. Technology that can
make staff more efficient and effective may well be cost neutral or
cost-saving.
Only one study in this group of included studies commented on
the “user satisfaction in terms of ease among health care profes-
sionals” (Wakefield 2008) stating that there was no significant dif-
ference in the nurses perceptions in interactions between video
and telephone support.
It was reported elderly CHF participants were more than able to
copewith technological monitoring. Studies reported that patients
usually withdrew because of hearing or health literacy issues and
some simply preferred not to add healthcare technology into their
busy lives (Clark 2007b; Cleland 2005 (Telemon)).
Technology in this area is not static and rapid developments create
opportunities and new problems. New sensors can offer more ac-
curate and robust reading or new clinical variables, such as cardiac
output and lung congestion using bio-impedance, cardiac func-
tion by acoustic or ballisto cardiography or more accurate blood
pressures using plethysmography. However, the biggest revolution
in this area is the development of tools that analyse the data au-
tomatically and provide analyses and advice to both patients and
health professionals in making care decisions. These can give pa-
tients more control in managing their problems and much more
personalised health-care. Expert systems that arise from telemon-
itoring are likely to form the basis of electronic patient records,
which may be accessed by all those engaged in the care of the
patient, as well as the patient themselves. This is currently the
subject of a major European Union initiative in telehealth called
HeartCycle (HeartCycle).
Strengths and weaknesses of this review
The major strength and advantage of our review is the quantifica-
tion of the benefit of structured telephone support and telemon-
itoring in the absence of home visits or more the standard clinic
follow-up which will now identify for clinicians and healthcare
service planners the value of each of the ’building blocks’ in con-
temporary CHF disease management programmes, allowing pro-
grammes to be customised according to needs. Another strength
of our systematic review and meta-analysis is that we have consid-
ered and synthesised evidence on almost all aspects from which an
effect of these interventions is important (mortality, hospitalisa-
tions, length of stay, quality of life, acceptability, functional capac-
ity and cost). We have also captured several previously unidenti-
fied RCTs of structured telephone support or telemonitoring and
have highlighted several studies for which results once published
will be included in future updates of this review. In addition, 14 of
the primary study authors whom we contacted provided us with
additional unpublished details or outcome data from their studies.
Like any systematic review and meta-analysis, our findings are
only as good as the studies which met our inclusion criteria. Fu-
ture updates of this review will incorporate new data along with
the findings of studies which are currently underway but not yet
completed (Chaudry 2007 (Tele-HF); Kohler 2006; Kulshreshtha
2008a). We were unable to stratify results according to age, func-
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tional class or sex as outcomes were not reported in a manner that
allowed us to extract this sub-group specific data. We were unable
to consider ’patient-years’ as the denominator for our meta-anal-
ysis in order to adjust for the differing lengths of follow-up of the
included studies as these data were very rarely reported.
We were challenged in correctly identifying all of the outcomes
available to report for each included study by the multiple pub-
lications arising from some of the included studies. Many stud-
ies published hospitalisation and mortality findings in one paper,
cost findings in another, and quality of life, acceptability and ad-
herence in another publication. Often these multiple publications
were published with a different order or list of authors and the
study was not always clear to identify from the title of the paper
or the abstract. Despite this challenge, we are confident that we
have captured reported outcomes which are currently available for
the studies we have included. Future publications arising from
RCTs of structured telephone support and telemonitoring should
be published in a manner which permits easy identification of the
study if outcomes are to be published in multiple publications.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Telemonitoring and structured telephone support interventions
for assisting in the day-to-day management of patients with CHF
are beneficial and may play a significant role in the care of ’stan-
dard’ management of CHF in the developed world for specific
patients. It may be deduced from these findings that there may be
additive or synergistic benefits of structured telephone support or
telemonitoring as part of home or clinic based specialised heart
failure management programmes.
Implications for research
• There are clear benefits of such programmes on outcomes
for patients with CHF.
• Given the weight of evidence from such trials further
randomised controlled trials of structured telephone support or
non-invasive telemonitoring in comparison to usual care
(cardiologist and general practitioner care) are not recommended.
• Future publication of findings of structured telephone
support or telemonitoring interventions, and those already
published, should present results which would allow
stratification of the benefits of such programmes across the heart
failure patient population, in particular, outcomes should be
presented for both men and women and for age groups (young,
middle-aged, old, and elderly) separately.
• More work is required on the business models underlying
the cost-effectiveness of telemonitoring in particular. High
capital acquisition costs with low running costs argue for long-
term monitoring. However, renting equipment changes this
balance and argues for monitoring over shorter periods of high-
risk or the need for intensive monitoring and education. The
business models will help define how the clinical community use
the technology.
• Future research into ’remote monitoring’ of patients with
CHF should not discount the value of these non-invasive
interventions over preference for other ’invasive’ forms of remote
monitoring.
• Future research should focus on intervention intensity, so
that the benefits of structured telephone support and
telemonitoring performed at different intensities alongside other
proven disease management strategies may be elucidated and the
’best’ multi-modal strategy identified for each patient sub-group.
The aim for the future use of structured telephone support and
telemonitoring should be to use these interventions to tailor
CHF disease management programmes to the population needs
and resources, to the geography of the population and most
importantly, to patient preferences.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Angermann 2007
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 708 patients hospitalised for symptomatic systolic CHF with LVEF ≤ 40%.
Mean age 68 years.
71% of participants were male.
Germany.
Interventions Structured telephone support.
Patients randomised to the disease management arm received telephone-based monitor-
ing and modular education delivered by trained nurses that included educational mate-
rial/self-monitoring schemes and multidisciplinary advice. These patients were required
to attend six monthly visits to a CHF clinic.
Usual care consisted of care provided by the patients GP plus six monthly visits to a
CHF clinic.
Outcomes All cause mortality, time-to-first-event (all-cause death and hospitalisation), days alive
and out of hospital, NYHA class, quality of life.
Six month follow-up.
Notes Abstract.
Final data still to be published. Contacted author no further outcome data offered until
publication but methodology of trial and type of intervention confirmed with authors.
The extracted data is from a published abstract.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Unable to assess. Abstract only.
Allocation concealment? Unclear Unable to assess. Abstract only.
Blinding?
Intervention
Unclear Unable to assess. Abstract only.
Incomplete outcome data addressed?
All outcomes
Unclear Unable to assess. Abstract only.
Free of selective reporting? Unclear Unable to assess. Abstract only.
Was the study powered to detect differences
in outcomes.?
Unclear Unable to assess. Abstract only.
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Angermann 2007 (Continued)
Were the study groups comparable at base-
line?
Unclear Unable to assess. Abstract only.
Was the study reported according toCON-
SORT guidelines?
Unclear Unable to assess. Abstract only.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Unable to assess. Abstract only.
Antonicelli 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants Telemonitoring.
57 patients hospitalised for worsening symptoms and signs of CHF with NYHA class
II-IV, evidence of pulmonary congestions on chest x-ray and EF < 40%. Patients with
NYHA class II-III with an EF > 40% and diastolic LV dysfunction were also included.
Mean age 78 years.
61% of participants were male.
Italy
Interventions Patients randomised to home telemonitoring-based care were contacted by telephone at
least once a week to collect information on symptoms and treatment adherence as well as
BP, HR, weight and 24h urine output on the previous day. A weekly ECG transmission
was also obtained. Patients were then evaluated and their regimen altered when necessary
based on this data. Additionally, clinic visits were performed when required based on the
data collected or telephone interviews.
Usual care involved receiving stand care based on routinely scheduled clinic visits (ev-
ery four months) performed by a team specialized in CHF patient management. These
subjects were also contacted monthly by telephone to collect data on new hospital ad-
missions, complications and death. Additional clinic visits were performed whenever
required when clinical status altered.
Outcomes Combined rate of mortality and hospitalisation, these rates considered individually,
quality of life.
12 month follow-up.
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Method of randomisation not stated.
Allocation concealment? Unclear Not detailed.
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Antonicelli 2008 (Continued)
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Yes No evidence of incomplete outcome data.
Free of selective reporting? Yes No evidence of selective outcome report-
ing.
Was the study powered to detect differences
in outcomes.?
Yes Power calculation performed for sample
size for primary outcome - combined rate of
mortality and hospitalisation. Study pow-
ered for this outcome.
Were the study groups comparable at base-
line?
No Several variables were different between the
control and intervention groups at baseline.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Yes Diagnosis of heart failure based on presence
of CHF signs and symptoms, pulmonary
congestionon chest x-ray, and ejection frac-
tion on echocardiogram.
Balk 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 214 patients with CHF and NYHA class I-IV.
Mean age 66 years.
70% of participants were male.
The Netherlands.
Interventions Telemonitoring.
Patients in the Intervention group were provided a MOTIVA system (TV-channel pro-
viding educational material, reminders of medication, health related surveys and moti-
vational messages to encourage the prescribed lifestyle regimen) in addition to scheduled
cardiologist appointments. A subgroup of intervention patients also received automated
BP and weight devices that automatically communicated readings via the telephone
(those who had been hospitalised in the prior year for HF). Patient guidance followed a
personalised plan.
Control subjects were followed by their cardiologists and HF-nurses according to stan-
dard local practice.
All patients recorded all contacts with health care professionals and hospital admissions.
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Balk 2008 (Continued)
Outcomes All-cause hospital days per year, days alive and out of hospital, quality of life, knowledge
of disease, self-care.
288 days - mean follow-up.
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “Randomisation was performed in a 1:
1 ratio, in randomly permuted blocks of
30 per participating centre. Randomisation
was independently performed...via a spe-
cial Web-based application” p1138.
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Not detailed.
Appears that an independent organiza-
tion that performed the randomisation also
analysed the data.
Incomplete outcome data addressed?
All outcomes
Yes No evidence of incomplete outcome data.
Free of selective reporting? Yes No evidence of selective outcome report-
ing.
Was the study powered to detect differences
in outcomes.?
Unclear No power analysis for sample size - authors
state that “...a meaningful power analysis
was not possible because of absence of data
in the literature and insufficient data from
hospitals on hospital admissions for these
patients, who had not necessarily had a re-
cent admission to hospital for heart failure
treatment...” p1138.
Were the study groups comparable at base-
line?
No Some slight differences were observed be-
tween the two groups at baseline.
Was the study reported according toCON-
SORT guidelines?
Unclear Not reported using CONSORT guide-
lines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Specific clinical criteria to confirm heart
failure diagnosis not detailed. Patients with
chronic heart failure in NYHA class I-IV
and under the care of cardiologists were el-
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Balk 2008 (Continued)
igible.
Barth 2001
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 34 patients discharged from acute care to home with primary diagnosis of CHF.
Mean age 75 years.
47% of participants were male.
USA
Interventions Structured telephone support.
Structured nurse-managed telephonic post-discharge program involving pre-discharge
education plus post discharge telephone follow-up. Structured interaction at 72 hours,
144 hours, and then fortnightly.
The control group received routine discharge teaching at the time of discharge as per
hospital procedure. Patients were contacted at two months for collection of data.
Outcomes Mortality, rehospitalisation, physician and emergency department visits, quality of life,
cost of the intervention.
Three months follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Method of randomisation not stated.
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Unclear Not detailed.
Free of selective reporting? Unclear Unable to assess, not detailed.
Was the study powered to detect differences
in outcomes.?
Unclear Not detailed.
Were the study groups comparable at base-
line?
Yes No significant differences observed in base-
line characteristics between the two groups.
Was the study reported according toCON-
SORT guidelines?
No Studywas not reported according toCON-
SORT guidelines.
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Barth 2001 (Continued)
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
Blum 2007 (MCCD)
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 204 subjects with heart failure.
Mean age 72 years.
71% of participants were male.
USA
Interventions Telemonitoring.
All subjects were givenwrittenmaterial about heart failure and self-management activities
such as daily weights, medication administration, signs and symptoms of worsening
heart failure and were given an opportunity to ask questions or seek clarification as the
handout was discussed.
The usual care group was not contacted again until time to schedule the six-month
follow-up appointment.
Intervention subjects were instructed to use the scale, blood pressure cuff/heart rate
monitor and the heart rhythm strip monitor at the same time each day. The transmit-
ted data was then compared to individually assigned parameters based on the subject’s
admission and subsequent evaluations. Readings outside these parameters were flagged
for the nurse practitioner (NP) who did the monitoring. This NP, who had extensive
experience in the management of heart failure patients contacted the subject to gather
more information and, if appropriate, adjusted medications, usually diuretics. There
were no specific protocols as to the management decisions and decisions were based on
the NP’s experience and/or consultation with the subject’s cardiologist. If no flags were
noted over the period of one month, the subjects were called just to maintain contact,
provide encouragement and answer any questions they might have. Subjects were en-
couraged to call the NP any time they wished and they were given the phone number
of the direct line to the NP’s office. Reports of weight and vital sign trends were sent to
participating cardiologists’ office prior to office visits. Monitoring was performed seven
days a week.
Outcomes All-causemortality, hospitalisations (as provided by the authors).Quality of life using SF-
36 andMinnesota Living with Heart Failure Questionnaire (presented in abstract). BNP
(outcomes not included in review as only mortality and hospitalisation data provided)
12 month follow-up.
Notes Abstract and author communication.
Meta-analysis performed using number of patients randomised (n = 204).
Risk of bias
Item Authors’ judgement Description
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Blum 2007 (MCCD) (Continued)
Adequate sequence generation? Yes “The subject’s identification information
was entered into the Mathematica Pol-
icy Research (MPR) randomisation web-
site and the designation of participant (tele-
monitored group) or control (usual care)
was returned” author correspondence.
Allocation concealment? Yes Randomization performed after informed
consent given by participant.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Yes “Two subjects declined to continue after
signing consent and only partial or no data
were collected on them, one in the usual
care group andone in themonitored group.
Therefore, complete baseline data was col-
lected on 202 subjects. One subject com-
pleted all of the first visit data and then de-
clined to accept themonitoring equipment
when it was delivered. These subjects were
eliminated from the data analysis leaving
201 subjects; 100 in the usual care group
and 101 in the monitored group” author
correspondence.
Free of selective reporting? Unclear Unable to assess. Abstract only.
Was the study powered to detect differences
in outcomes.?
Unclear Unable to assess. Abstract only.
Were the study groups comparable at base-
line?
Unclear Unable to assess. Abstract only.
Was the study reported according toCON-
SORT guidelines?
Unclear Unable to assess. Abstract only.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Unable to assess. Abstract only.
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Capomolla 2004
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 133 patients discharged from specialist CHF unit to home.
Mean age 57 years.
88% of participants were male.
Italy
Interventions Telemonitoring.
Daily communication of vital signs (including weight, systolic BP, HR) and symptoms
with review by nurses and physicians. Access to medical staff via phone as needed was
available.
Usual care consisted of a referral to the patients primary care physician or cardiology
department at discharge. Post-discharge care was governed by the care provider.
Outcomes Mortality, re hospitalisation, emergency department visits, compliancewith intervention.
12 month follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Method of randomisation not stated.
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Unclear Not detailed.
Free of selective reporting? Yes No evidence of selective outcome report-
ing.
Was the study powered to detect differences
in outcomes.?
Unclear Sample size calculation not detailed.
Were the study groups comparable at base-
line?
Yes No significant differences in baseline vari-
ables evident.
Was the study reported according toCON-
SORT guidelines?
No Study not reported according to CON-
SORT guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
61Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cleland 2005 (Telemon)
Methods Randomised controlled trial; multiple intervention arms and control (usual care) arm.
Participants 426 patients with a recent admission for heart failure and LVEF < 40%.
Mean age 67 years.
77% of participants were male.
Germany, Netherlands, UK
Interventions Structured telephone support; telemonitoring.
Patients assigned to the nurse telephone support arm received a telephone call eachmonth
by a heart failure specialist nurse to assess their symptoms and current medications.
Patients assigned to telemonitoring received the nurse telephone support and had their
weight, BP and ECG monitored twice daily.
Usual care consisted of a management plan forwarded to the patient’s primary care
physician, who was asked to implement it. If the practice involved nurse titration of
drugs this was allowed. Patients were assessed at a research clinic every four months;
contact with the clinic was discouraged between clinic visits.
Outcomes Mortality, rehospitalisation, compliance with intervention.
240 day and 450 day follow-up.
Notes Three armed study with both telephone and telemonitoring.
Included in previous systematic review and meta-analysis Clark 2007a.
Results included in meta-analysis are from 240 day follow-up.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Random permuted blocks - correspon-
dence from author.
Allocation concealment? Yes After consent and collection of baseline
data an independent statistical centre was
contacted - correspondence from author.
Blinding?
Intervention
Unclear Not stated.
Incomplete outcome data addressed?
All outcomes
Yes ”...Four were lost to follow-up and 12 de-
clined to comply with regular telemonitor-
ing“ p1659. ”
“Analyses were conducted by intention-to-
treat” p1659.
Free of selective reporting? Yes Selective outcome reporting not evident.
Was the study powered to detect differences
in outcomes.?
Yes Power calculation performed. Study pow-
ered for the primary outcome days lost be-
cause of death or hospitalisation in acute
62Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cleland 2005 (Telemon) (Continued)
medical/surgical beds for any reason dur-
ing 450 days, after an interim analysis
the duration of follow-up was reduced to
240 days.
Were the study groups comparable at base-
line?
Unclear The study groups appear to be similar at
baseline.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according the CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Unable to assess.
Cleland 2005(Struct Tele)
Methods Randomised controlled trial; multiple intervention arms and control (usual care) arm.
Participants 426 patients with a recent admission for heart failure and LVEF < 40%.
Mean age 67 years.
77% of participants were male.
Germany, Netherlands, UK
Interventions Structured telephone support; telemonitoring.
Patients assigned to the nurse telephone support arm received a telephone call eachmonth
by a heart failure specialist nurse to assess their symptoms and current medications.
Patients assigned to telemonitoring received the nurse telephone support and had their
weight, BP and ECG monitored twice daily.
Usual care consisted of a management plan forwarded to the patient’s primary care
physician, who was asked to implement it. If the practice involved nurse titration of
drugs this was allowed. Patients were assessed at a research clinic every four months;
contact with the clinic was discouraged between clinic visits.
Outcomes Mortality, rehospitalisation, compliance with intervention.
240 day and 450 day follow-up.
Notes Three armed study with both telephone and telemonitoring.
Included in previous systematic review and meta-analysis Clark 2007a.
Results included in meta-analysis are from 240 day follow-up.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Random permuted blocks - correspon-
dence from author.
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Allocation concealment? Yes After consent and collection of baseline
data an independent statistical centre was
contacted - correspondence from author.
Blinding?
Intervention
Unclear Not stated.
Incomplete outcome data addressed?
All outcomes
Yes ”...Four were lost to follow-up and 12 de-
clined to comply with regular telemonitor-
ing“ p1659. ”
“Analyses were conducted by intention-to-
treat” p1659.
Free of selective reporting? Yes Selective outcome reporting not evident.
Was the study powered to detect differences
in outcomes.?
Yes Power calculation performed. Study pow-
ered for the primary outcome days lost be-
cause of death or hospitalisation in acute
medical/surgical beds for any reason dur-
ing 450 days, after an interim analysis
the duration of follow-up was reduced to
240 days.
Were the study groups comparable at base-
line?
Unclear The study groups appear to be similar at
baseline.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according the CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Unable to assess.
de Lusignan 2001
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 20 patients with heart failure confirmed by cardiologist, identified from the database of
an academic general practice.
Mean age 75 years.
Number or proportion of males and females not specified.
UK.
Interventions Telemonitoring.
Telemonitoring of vital signs (pulse, BP, weight) and clinical status daily assessed daily
by nurses along with video consults with a nurse weekly for three months, fortnightly
for three months, then monthly.
Usual care consisted of standard general practice treatment; in addition they had their
pulse, BP and weight measured quarterly. They were evaluated in the same manner as
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the intervention group.
Outcomes Mortality, compliance with intervention and medication, patient satisfaction, quality of
life.
12 month follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “The first 20 patients identified by random
table allocation 10 to the telemedicine and
10 to the control group...” p724.
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Unclear Not detailed.
Free of selective reporting? Yes No evidence of selective outcome report-
ing.
Was the study powered to detect differences
in outcomes.?
Unclear Sample size calculation not detailed.
Were the study groups comparable at base-
line?
Unclear Not detailed.
Was the study reported according toCON-
SORT guidelines?
No Study not reported according to CON-
SORT guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
DeBusk 2004
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 462 patients hospitalised with a provisional diagnosis of CHF from Kaiser Permanente.
Mean age 72 years.
51% of participants were male.
USA.
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Interventions Structured telephone support.
Standardised telephonic physician directed nurse-managed case management, involving
CHF lifestyle education and medication management. Patients contacted weekly for 6
weeks, biweekly for 8 weeks and then monthly and bimonthly.
Usual care not clearly defined, but was provided by the participating Kaiser Permanente
medical centres, appeared to involve a high frequency of all of kinds of follow-up clinic
visits (13 in 12 months following hospitalisation).
Outcomes Mortality, rehospitalisation, emergency and outpatient department visits, prescription
of recommended pharmacotherapy.
12 months follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “Equal numbers of patients were allocated
to the 2 groups in each medical center by
using the Efron procedure”. p607.
Allocation concealment? Yes “Research staff who were not associated
with delivering the intervention randomly
assigned patients to treatment conditions
by using sealed assignments.” p607
Blinding?
Intervention
Yes “Research staff who were not associated
with, and were blinded to, the intervention
conditionsmeasured health outcomes at 12
months” p608.
“Two cardiologists who were not associated
with implementing the intervention re-
viewed medical records on deaths, rehospi-
talisation, and emergency department visits
to determine whether these events were pri-
marily due to heart failure or due to other
causes”. p608.
Incomplete outcome data addressed?
All outcomes
Yes “During the first year of follow-up, 23 pa-
tients (3%) dropped out of the trial (8 in
the treatment group and 15 in the usual
care group)” p608.
The analysis was by intention-to-treat.
Free of selective reporting? Yes No evidence of selective reporting.
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Was the study powered to detect differences
in outcomes.?
Yes Power calculation performed. Study pow-
ered for risk for rehospitalization for heart
failure.
Were the study groups comparable at base-
line?
Yes No statistically significant differences in the
two groups at baseline.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Yes Based on signs and symptoms of heart fail-
ure: shortness of breath (dyspnoea at
rest, including orthopnoea or paroxysmal
nocturnal dyspnoea) and at least 1 corrobo-
rating clinical sign (pulmonary congestion
on examination, including rales, crackles,
or wheezes) or radiologic abnormality (pul-
monary congestion on chest radiograph)
consistent with heart failure.
DeWalt 2006
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 127 patients with confirmed HF, NYHA class II-IV symptoms within the last 3 months
and currently taking furosemide from the University of North Carolina (UNC) General
Internal Medicine Practice.
Mean age 62.5 years.
47% of participants were male.
USA.
Interventions Structured telephone support.
Intervention patients received self-care education, picture-based educational materials
with verbal explanation, a digital scale and scheduled follow-up phone calls (days 3, 7,
14, 21, 28, 56) and monthly during months 3-6 for reinforcement of education and
revision of individualised care plan.
Control group patients received a general heart failure education pamphlet and usual
care from their primary physician (not specified). Data collection occurred at 6 and 12
months via in-person interview and medical record review.
Outcomes Mortality, all-cause re-hospitalisation, HF-related quality of life, HF self-efficacy, HF
knowledge, reported weight monitoring (self-management behaviour).
12 month follow-up.
Notes Meta-analysis performed using number of patients randomised (n = 127)
Risk of bias
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Item Authors’ judgement Description
Adequate sequence generation? Yes ”..randomised patients by concealed allo-
cation based on a random number genera-
tor“ p2.
Allocation concealment? Unclear Unclear if randomisation performed before
or after consent provided.
Blinding?
Intervention
No ”Research assistant was not blinded to pa-
tients study group” p3.
Incomplete outcome data addressed?
All outcomes
Yes “Patients who did not return any phone
calls anddidnot return for follow-up assess-
ment did not have outcome data for analy-
sis. Patients who withdrew from the study
were censored at the time of withdrawal;
any data collected prior to withdrawal were
included in the analysis” p5.
“Of those randomised to the control group,
1 never returned after the first visit, 1 with-
drew during the study and 4 died during
the study. Follow-up was completed for all
of the remaining participants (98%)” p5.
Free of selective reporting? Yes No evidence of selective reporting.
Was the study powered to detect differences
in outcomes.?
Unclear Power calculation for sample size to detect
differences in heart failure-related quality
of life. Study not powered to detect differ-
ences in hospitalizations.
Were the study groups comparable at base-
line?
No At baseline, most characteristics were sim-
ilar between the two groups.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Yes “Patients had to have a clinical diagnosis
of heart failure confirmed by their primary
provider through
a direct interview, and one of the follow-
ing: 1) chest x-ray findings consistent with
heart failure, 2) ejection fraction <40% by
any method, or 3) a history of periph-
eral edema. They also had to have New
York Heart Association class III-V symp-
toms within the last 3 months” p2.
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Galbreath 2004
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 1069 patients with symptoms of CHF and documented systolic (mean EF 35%) or
diastolic dysfunction (echo confirmed).
Mean age 71 years.
71% of participants were male.
USA.
Interventions Structured telephone support.
All intervention patients received bathroom scales and were designated a disease manager
who administered the disease management program telephonically. Initial call frequency
was weekly then transitioned to monthly for the duration of the study. Call frequency
could be adjusted for acuity or need. After each call a call summary was faxed to the
patients primary care provider.
An additional randomisation was performed within the intervention arm, with some
participants provided with in-home technology (BP monitor, pulse oximeter) - these
measurements were reported by the patient to the disease manager, but the data were
not forwarded to the primary care provider. These patients also wore activity monitors
at regular intervals and had six-monthly measurement of thoracic bioimpedance cardiac
output - these data were not forwarded to the primary care physician.
The authors state: “because data derived from the technology were not used in clinical
management, we combined results from the two treatment groups for the purposes of
this analysis.”
Traditional care patients were managed as usual by their physicians.
Outcomes All-cause mortality, six-min walk performance, functional therapeutic class improve-
ment, total healthcare costs. Improvement in ejection fraction improvement and medi-
cation adherence were assessed in a subgroup.
18 month follow-up.
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “Participants were randomised in a 2:1
ratio between the treatment and control
groups” p3519.
Method of randomisation not detailed.
Allocation concealment? Yes Randomisation performed after informed
consent obtained.
Blinding?
Intervention
No “Reviews were performed by study staff,
consisting of physicians, nurses, and ancil-
lary health providers” p3519.
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Incomplete outcome data addressed?
All outcomes
No Some evidence of attrition of study partic-
ipants but actual numbers not presented.
Free of selective reporting? Yes No evidence of selective reporting.
Was the study powered to detect differences
in outcomes.?
Yes Sample size calculation performed; study
powered for primary and secondary out-
comes.
Were the study groups comparable at base-
line?
Unclear Diastolic blood pressure for patients with
systolic heart failure the only baseline vari-
able that was statistically significant be-
tween the groups.
Was the study reported according toCON-
SORT guidelines?
No Study not reported according to CON-
SORT guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Yes Based on echocardiographic findings.
Gattis 1999 (PHARM)
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 181 patients with heart failure being evaluated in cardiology clinic.
Mean age 67 years.
68% of participants were male.
USA.
Interventions Structured telephone support.
Clinical pharmacist-led medication review and patient education. Regularly scheduled
telephone contact (at two, 12 and 24 weeks) to detect clinical deterioration early.
The control group received usual care which did not include the pharmacist providing
recommendations regarding drug therapy to the attending physician or providing edu-
cation to the patient. Patient assessment and education were provided by the attending
physician and/or physician assistant or nurse practitioner. The patient was contacted by
the pharmacist via telephone to identify clinical events.
Outcomes Mortality, rehospitalisation, medication prescription.
Six month follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
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Adequate sequence generation? Yes “...patients were randomised according
to a computer-generated randomisation
scheme..” p1940.
Allocation concealment? No Not detailed.
Blinding?
Intervention
Yes “Clinical events and current drug therapy
were documented on follow-up data collec-
tion forms during telephone follow-up or
return visits” p1941.
“..clinical events were adjudicated by a
blinded physician clinical events commit-
tee using standard adjudication forms”
p1941.
Incomplete outcome data addressed?
All outcomes
Unclear Not detailed.
Free of selective reporting? Yes No evidence of selective reporting.
Was the study powered to detect differences
in outcomes.?
Unclear Power calculation not detailed.
Were the study groups comparable at base-
line?
No Baseline characteristics were similar be-
tween the groups, with the median age of
patients in the intervention group slightly
higher.
Was the study reported according toCON-
SORT guidelines?
No Study not reported according to CON-
SORT guidelines (losses to follow-up not
detailed).
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
GESICA 2005 (DIAL)
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 1518 outpatients with stable CHF.
Mean age 65 years.
71% of participants were male.
Argentina.
Interventions Structured telephone support.
Nurses trained in themanagement of patients withCHFperformed structured telephone
follow-up involving based on adherence to diet and treatment, monitoring of symptoms,
control of fluid retention and daily physical activity. Patients were contacted four times
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in the first fortnight and then as needed.
Patients in the control group were followed by their attending cardiologists and received
care similar to the intervention group
Outcomes Mortality, rehospitalisation, quality of life.
Mean 16 month follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “We then used concealed randomisation
lists to do permuted block randomisation
stratified by attending cardiologist ” p2.
Allocation concealment? Yes After provision of consent, patient’s cardi-
ologist contacted study centre (BMJ com-
ment).
Blinding?
Intervention
Yes “The clinical events committee, which was
blinded to the patients’ treatment group as-
signment, adjudicated all outcomes” p2.
Incomplete outcome data addressed?
All outcomes
Yes “Follow-up was completed in 1511
(99.5%) randomised patients” p2.
“We based all analyses on the intention to
treat principle” p2.
Free of selective reporting? Yes No evidence of selective reporting.
Was the study powered to detect differences
in outcomes.?
Unclear Power calculation performed. Study was
powered for the primary endpoint - all
cause mortality or admission to hospital for
worsening heart failure.
Were the study groups comparable at base-
line?
Yes The baseline variables were similar between
the two groups.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
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Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 460 confirmed CHF patients with LVEF < 40% and at least one hospitalisation for acute
HF in the prior year.
Mean age 57 years.
85% of participants were male.
Italy.
Interventions Telemonitoring.
Home-Based Telemanagement (HBT) patients received a one-lead trace portable device
that transferred results via telephone where a nurse was available for interactive telecon-
sultation. Scheduled standardised telemonitoring appointments were performed every
week to15 days depending on HF severity discussing symtomology, medications, self-
care and, if required, the transmission of the ECG trace.
Usual care consisted of patients being referred to their primary care physician (PCP) and
cardiologist for clinicalmanagement. These patients attended a two-weeks post-discharge
PCP appointment and a structured follow-up outpatient cardiologist appointment at 12
months.
Outcomes Unplanned cardiovascular hospital readmissions, hospitalisation for HF, haemodynamic
instability episode occurrence, cardiovascular mortality.
12 month follow-up.
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “Random permuted blocks for each center
were used to allocate patients to treatment
groups” p193.
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Yes “...one patient in UC group and four in
HBT group were lost to follow-up” p196.
“Analyses were conducted according to the
intention-to treat approach” p195.
Free of selective reporting? Yes Selective outcome reporting not evident.
Was the study powered to detect differences
in outcomes.?
Yes Sample size calculation performed for pri-
mary outcome - one-year readmission rate.
Study was adequately powered.
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Were the study groups comparable at base-
line?
No “The randomisation groups differed signif-
icantly only with regard to use of digitalis
and beta-blockers, which was respectively
higher and lower in the UC group” p196.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Yes “...left ventricular ejection fraction (LVEF)
< 40% and at least one hospitalisation for
acute HF in the previous year” p193.
Goldberg 2003 (WHARF)
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 280 patients hospitalised with NYHA Class III-IV, with a LVEF < 35%.
Mean age 59 years.
68% of participants were male.
USA.
Interventions Telemonitoring.
Daily transmission of weight and symptoms using a customised monitor, data was re-
viewed daily by nurses and concerns reported to the physician.
Patients in the control group were instructed to contact their physician for weight in-
creases of more than a pre-specified amount or if their symptoms of heart failure wors-
ened. They had a weight log to bring to visits. Follow-up visits, other than study visits
were at the discretion of the treating physician. Telephone contacts were permitted at
the discretion of the treating physician or nurse.
Outcomes Mortality, rehospitalisation, emergency department visits, quality of life, patient satis-
faction, compliance with intervention.
Mean six month follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Method of randomisation not detailed.
Allocation concealment? Yes Randomised performed after informed
consent obtained.
Blinding?
Intervention
Yes ”To insure that all hospitalizations, emer-
gency room visits, and deaths were iden-
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tified, all patients were contacted by tele-
phone on a monthly basis by a non medi-
cal surveyor (blinded to patient treatment
group randomisation), located outside of
the enrolment sites and Alere monitoring
centre” p707.
Incomplete outcome data addressed?
All outcomes
Yes “During the study, 32 patients either re-
fused follow-up data collection or were lost
to follow-up. Seven patients received car-
diac transplantation and were censored on
the day of transplant. Excluding deaths,
there was no difference between groups in
the percentage of patients who failed to
complete six months of follow-up” p707.
Free of selective reporting? Unclear Some nominated outcomes (satisfaction)
were not reported.
Was the study powered to detect differences
in outcomes.?
No Sample size calculation not reported.
Were the study groups comparable at base-
line?
Yes Groups were comparable at baseline.
Was the study reported according toCON-
SORT guidelines?
No Study not reported according to CON-
SORT guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Yes “...a left ventricular ejection fraction, mea-
sured within 6 months of enrolment, of ≤
35%” p706.
Kielblock 2007
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 502 participants discharged after a hospitalisation with heart failure or with a confirmed
diagnosis from ICD codes from hospital insurance data.
Mean age 74 years.
51% of participants were male.
Germany.
Interventions Telemonitoring.
The intervention group all received a set of electronic scales which were attached to the
monitoring centre via modem and regular CHF information and education via phone.
Daily weight was monitored and responded to by CHF specialist team members. 72
patients also had BP monitored by this method. Control group participants received
CHF education from GP.
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The first 50 patients in the intervention group were visited at home by the health coach
at the start of the study in order to set-up the telemetric equipment and to assess their
ability to use the devices.
Patients were contacted whenever their body weight exceeded a threshold value, were
phoned by a designated personal adviser and received regular informative material and
advice by specialist medical personnel. Patients’ general practitioners sent them follow-
up reports.
Control group described as patients who had not received the described telemetric in-
tervention.
Outcomes Mortality, hospital stay duration, hospital and drug costs, total costs per patient.
12 month follow-up.
Notes Translated from German. Authors provided details in English and additional data.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? No ”Participants were randomised on the basis
of date of birth to either the control group
(date of birth 21st-31st of the month; n
= 251) or assigned as candidates to the
management programme (date of birth 1st-
20th of the month; n = 746)“ from details
of the study provided by the study authors.
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Unclear Not detailed.
Free of selective reporting? Unclear Unable to assess. Not detailed.
Was the study powered to detect differences
in outcomes.?
Unclear Not detailed.
Were the study groups comparable at base-
line?
No Slightly older (Intervention 71 years vs
Control 76 years) and more females (Inter-
vention 42.6% vs Control 55.3%)
Was the study reported according toCON-
SORT guidelines?
No No CONSORT Study Flow chart pre-
sented
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Was the diagnosis of heart failure defined
and appropriate?
Unclear Yes ”patienten mit den relevant ICD-Diag-
nosen (150.1, 150.11-19 150.9) zur chro-
nisch Herzinsuffizienz wurden Datenbe-
stand der KKH p 418
Krum 2009 (CHAT)
Methods Cluster randomised controlled trial. Computer generated random sequence.
GP practices were the unit of randomisation. GPs were not blinded to allocation group
before recruiting and consenting patients.
Participants 405 patients with a recent hospital discharge due to a primary diagnosis of heart failure
with an EF of 40% and in NYHA class II-IV were randomised to either usual care or
usual care plus telephone monitoring performed at least once per month.
Mean age - not reported.
% Men - not reported.
Australia.
Interventions Structured telephone support
Nurse-led telephone monitoring using the Telewatch System (Baltimore).
Patient responded to computer generated CHF self-monitoring questions by pressing
the numbers on the touch phone key pad.
Nurse survey in-coming calls daily and responded to pre-set variations to patients pa-
rameters.
Usual care discharge follow-up with GP and copy of guidelines.
Outcomes The primary endpoint was the change in Packer clinical composite score. HRQOL, BNP.
Patients were assessed by a blinded reviewer at baseline and then after 6 and 12 months.
12 months follow-up.
Notes Final results not published.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Unable to assess. Abstract only.
Allocation concealment? Unclear Unable to assess. Abstract only.
Blinding?
Intervention
Unclear Unable to assess. Abstract only.
Incomplete outcome data addressed?
All outcomes
Unclear Unable to assess. Abstract only.
Free of selective reporting? Unclear Unable to assess. Abstract only.
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Was the study powered to detect differences
in outcomes.?
Unclear Unable to assess. Abstract only.
Were the study groups comparable at base-
line?
Unclear Unable to assess. Abstract only.
Was the study reported according toCON-
SORT guidelines?
Unclear Unable to assess. Abstract only.
Was the diagnosis of heart failure defined
and appropriate?
Yes Unable to assess. Abstract only.
Laramee 2003
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 287 patients admitted to hospital with primary or secondary diagnosis of CHF LVSD <
40% or radiological evidence of pulmonary oedema.
Mean age 71 years.
54% of participants were male.
USA.
Interventions Structured telephone support.
Telephonic case management performed by one CHF nurse case manager, involving
four major components: early discharge planning, patient and family CHF education,
promotion of optimal CHF medications and 12 weeks of telephone follow-up.
Usual care consisted of standard care typical of a tertiary care hospital. It included inpa-
tient social service evaluation (25%), dietary consultation (15%), physiotherapy/occupa-
tional therapy (17%) and medication and CHF education by nurses. Post-discharge was
conducted by the patient’s own local physician, 44% received some home care services.
Outcomes Mortality, rehospitalisation, inpatient and outpatient costs, medication prescription and
adherence.
Three month follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “After simple randomisation of the first 42
patients resulted in large amounts of pa-
tients being assigned to one group or the
other, patients were randomised in blocks
of 8 to endure an even group allocation
across time” p810.
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Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Unclear “Patients who withdrew, died or were oth-
erwise lost before 90 days of follow-up were
censored on the day of early attrition”.
Free of selective reporting? No One secondary outcome not reported -
number of days until first readmission.
Was the study powered to detect differences
in outcomes.?
No Power calculation not detailed.
Were the study groups comparable at base-
line?
No Some variables differed between the study
groups.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Yes Clinical signs and symptoms and either ev-
idence of moderate-to-severe left ventric-
ular dysfunction or radiographic evidence
of pulmonary congestion and symptomatic
improvement following diuresis.
Mortara 2009 (Struct Tele)
Methods Randomised controlled trial; multiple intervention arms and control (usual care) arm.
Participants 461 heart failure patients with NYHA class II-IV and LVEF ≤ 40%.
Mean age 60 years.
85% of participants were male.
UK, Poland, Italy
Interventions Structured telephone support; telemonitoring.
Patients allocated to home telemonitoring were further randomised into 3 groups.
The first group (strategy 1) receivedmonthly supportive telephone contacts from a study
nurse to check on their clinical status.
The second group (strategy 2) received the same telephone support, but also transmitted
their vital signs and other data including details of changes in weight, BP and symp-
toms weekly by telephone. These patients also performedmonthly 24h cardiorespiratory
recordings which were not made available to the clinical team.
The third group (strategy 3) carried out the same measurements as strategy 2 patients,
but the monthly 24h cardiorespiratory recordings were made available for clinical man-
agement.
Usual care was only described as usual outpatient care.
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Outcomes Mortality and hospitalisation due to HF, all-cause mortality, all-cause hospitalisation,
bed-days occupancy (due to cardiovascular cause).
Mean 11.6 month follow-up.
Notes Strategies 2 and 3 combined and classed as telemonitoring.
Authors provided additional unpublished data.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “The randomisation list was generated
by the coordinating centre with separate
blocks held in each country” p313.
Allocation concealment? Yes “The individual patient allocation was to
be revealed only after the patient identifiers
(name, surname and the date of birth) had
been received at the national randomisa-
tion centre” p313.
Blinding?
Intervention
Yes “All endpointswere adjudicated by an inde-
pendent, blinded, Endpoint Committee”
p314.
Incomplete outcome data addressed?
All outcomes
Unclear “...18 patients dropped out of the study...”
p315.
No statement asserting that analyses were
performed as intention-to-treat.
Free of selective reporting? Unclear All-cause mortality listed as a secondary
outcome but not reported in publication
according to study group. Author con-
tacted for this information.
Bed days occupancy for all cardiovascular
causes listed as secondary outcome. Not
reported, unless “all-causes” is actually all
“cardiovascular causes”.
Was the study powered to detect differences
in outcomes.?
Yes Power calculation performed, study pow-
ered for both primary endpoints - bed-days
occupancy for HF in
acute medical/surgical beds and composite
endpoint of cardiac death and hospitalisa-
tion due to HF.
Were the study groups comparable at base-
line?
No Some variables differed between the study
groups.
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Was the study reported according toCON-
SORT guidelines?
Yes Reported according to CONSORT guide-
lines.
Was the diagnosis of heart failure defined
and appropriate?
Yes Based on NYHA class and echocardio-
graphic findings.
Mortara 2009 (Telemon)
Methods Randomised controlled trial; multiple intervention arms and control (usual care) arm.
Participants 461 heart failure patients with NYHA class II-IV and LVEF ≤ 40%.
Mean age 60 years.
85% of participants were male.
UK, Poland, Italy
Interventions Structured telephone support; telemonitoring.
Patients allocated to home telemonitoring were further randomised into 3 groups.
The first group (strategy 1) receivedmonthly supportive telephone contacts from a study
nurse to check on their clinical status.
The second group (strategy 2) received the same telephone support, but also transmitted
their vital signs and other data including details of changes in weight, BP and symp-
toms weekly by telephone. These patients also performedmonthly 24h cardiorespiratory
recordings which were not made available to the clinical team.
The third group (strategy 3) carried out the same measurements as strategy 2 patients,
but the monthly 24h cardiorespiratory recordings were made available for clinical man-
agement.
Usual care was only described as usual outpatient care.
Outcomes Mortality and hospitalisation due to HF, all-cause mortality, all-cause hospitalisation,
bed-days occupancy (due to cardiovascular cause).
Mean 11.6 month follow-up.
Notes Strategies 2 and 3 combined and classed as telemonitoring.
Authors provided additional unpublished data.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “The randomisation list was generated
by the coordinating centre with separate
blocks held in each country” p313.
Allocation concealment? Yes “The individual patient allocation was to
be revealed only after the patient identifiers
(name, surname and the date of birth) had
been received at the national randomisa-
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tion centre” p313.
Blinding?
Intervention
Yes “All endpointswere adjudicated by an inde-
pendent, blinded, Endpoint Committee”
p314.
Incomplete outcome data addressed?
All outcomes
Unclear “...18 patients dropped out of the study...”
p315.
No statement asserting that analyses were
performed as intention-to-treat.
Free of selective reporting? Unclear All-cause mortality listed as a secondary
outcome but not reported in publication
according to study group. Author con-
tacted for this information.
Bed days occupancy for all cardiovascular
causes listed as secondary outcome. Not
reported, unless “all-causes” is actually all
“cardiovascular causes”.
Was the study powered to detect differences
in outcomes.?
Yes Power calculation performed, study pow-
ered for both primary endpoints - bed-days
occupancy for HF in
acute medical/surgical beds and composite
endpoint of cardiac death and hospitaliza-
tion due to HF.
Were the study groups comparable at base-
line?
No Some variables differed between the study
groups.
Was the study reported according toCON-
SORT guidelines?
Yes Reported according to CONSORT guide-
lines.
Was the diagnosis of heart failure defined
and appropriate?
Yes Based on NYHA class and echocardio-
graphic findings.
Parati 2009 (ICAROS)
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 120 Patients (LVEF ≤ 40%) NYHA II-III.
Mean age 69 years.
75% of participants were male.
Italy
Interventions Telemonitoring.
Continuous monitoring of patient parameters (Daily-weight, urine output, fluid intake,
blood pressure, heart rate etc.) Hand held transmission device (Smart Phone / PDA) via
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broadband and wireless. Almarm sounds at medication times.
Regular questionnaires (Anxiety, Depression, Anger)
Usual Care; Conventional management, returned to medico practitioner and placed in
a system of visits to clinics and receiving materials at the clinic.
Outcomes Mortality, Hospitalisation and Emergency room visits
Cost and improvement in LVEF %
12 months follow-up.
Notes Data from Abstract / Conference Proceedings and contact with authors.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “Open randomised parallel-groups”
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Unable to assess.
Incomplete outcome data addressed?
All outcomes
Unclear Unable to assess.
Free of selective reporting? Unclear Unable to assess.
Was the study powered to detect differences
in outcomes.?
Unclear Unable to assess.
Were the study groups comparable at base-
line?
Yes According to preliminary data
Was the study reported according toCON-
SORT guidelines?
Unclear Unable to assess.
Was the diagnosis of heart failure defined
and appropriate?
Yes Echocardiogram LVEF ≤ 40%
Rainville 1999
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 38 patients aged ≥ 50 years discharged from hospital with heart failure.
Mean age 70 years.
50% of participants were male.
USA.
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Interventions Structured telephone support.
Usual care plus a pharmacist-led medication review, patient education, medication man-
agement prior to discharge and at Day 3, Day 7, 30 days, 90 days and 12 months via
telephone.
Usual care consisted of routine care and preparation for discharge including written
prescriptions, physician discharge instructions and a nurse review of diet, treatment
plans and medications. The nurses provided the patient with computer generated drug
information sheets. Patients were contacted by a pharmacist at 30 days, 90 days and 12
months to determine readmissions.
Outcomes Mortality, rehospitalisation, functional assessment score.
12 month follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Meta-analysis performed using number of patients randomised (n = 38).
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Method of randomisation not detailed.
Allocation concealment? Yes “Qualified patients were randomly as-
signed to a control group or an intervention
group, with the patients, nurses, and physi-
cians blinded to the randomisation results”
p1339
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Yes 38 patients randomised; two patients in in-
tervention group and one in control group
were excluded during the initial hospitali-
sation because test results showed normal
left ventricular function; long-term dialy-
sis was initiated or because the patient was
moving out of state after DC. One control
patient was lost to follow-upwithin the first
30 days after discharge and was excluded
from the analysis.
Final sample included 34 patients equally
divided between the two groups.
Free of selective reporting? Yes Selective outcome reporting not evident.
Was the study powered to detect differences
in outcomes.?
No Power calculation not detailed.
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Were the study groups comparable at base-
line?
No Some variables differed between the
groups.
Was the study reported according toCON-
SORT guidelines?
No Study not reported according to CON-
SORT guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
Ramachandran 2007
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 50 patients attending heart failure clinic with symptoms of CHF and LVEF < 40%.
Mean age 44.5 years.
78% of participants were male.
India.
Interventions Structured telephone support.
Intervention group patients were managed in the heart failure clinic and received disease,
medication and self-management education and telephonic disease management which
consisted of reinforcement of information and drug dose modification.
The control group was managed as per usual care in the heart failure clinic.
Outcomes Functional status, quality of life, hospitalisation rates, quality of care, drug usage, cost-
effectiveness.
Six month follow-up.
Notes Mortality not reported. No response from authors for further detail.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “An investigator, unaware of the patients’
demographic and clinical profile, using
a computer-generated list, initiated ran-
domisation” p68.
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Unclear Not detailed.
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Free of selective reporting? Unclear No evidence of selective outcome report-
ing.
Was the study powered to detect differences
in outcomes.?
No Power calculation not performed.
Were the study groups comparable at base-
line?
Unclear Baseline characteristics were similar be-
tween the groups.
Was the study reported according toCON-
SORT guidelines?
Yes Reported according to CONSORT guide-
lines.
Was the diagnosis of heart failure defined
and appropriate?
Yes CHF symptoms and LVEF > 40%.
Riegel 2002
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 358 patients discharged from hospital with heart failure.
Mean age 74 years.
49% of participants were male.
USA.
Interventions Structured telephone support.
Telephonic case management by a registered nurse using decision support software,
involving patient education and counselling and liaison with primary care physician.
Patients were telephoned within 5 days of discharge and thereafter at a frequency guided
by the software and case manager (mean 17 calls).
Usual care was not standardised, and no formal telephonic case-management was in exis-
tence at these institutions. These patients presumably received some education regarding
HF management prior to hospital discharge.
Outcomes Mortality, rehospitalisation, physician and emergency department visits, inpatient costs,
patient satisfaction.
Six month follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Method of randomisation not stated.
(Physicianswere the unit of randomisation)
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Allocation concealment? Yes “Physicians were not informed of the group
to which they were assigned” p706.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Unclear Not detailed.
Free of selective reporting? Yes Selective outcome reporting not evident.
Was the study powered to detect differences
in outcomes.?
No Sample size calculation not performed.
Were the study groups comparable at base-
line?
No Somedifferences in baseline characteristics.
Was the study reported according toCON-
SORT guidelines?
Unclear Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
Riegel 2006
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 135 hospitalised Hispanic patients with CHF.
Mean age 72 years.
46% of participants were male.
USA.
Interventions Structured telephone support.
Education, monitoring and guidance by bilingual-bicultural Mexican-American regis-
tered nurses via telephone case management standardised using decision support soft-
ware. Patients were contacted on average within 5 days of discharge and thereafter at a
frequency guided by the software and nurse case manager over a 6 month period (mean
13.5 calls to patients and 8.4 additional calls to families). Printed educational material
was provided monthly and upon request in the relevant language.
Usual care was not standardised and no formal disease management program existed at
these institutions. The standard of usual care was that patients were educated regarding
HF management before discharge, assuming that the nurse spoke the patient’s language
or someone bilingual was available to translate. In reality, only a small portion of staff
were bilingual .
Outcomes Mortality, re hospitalisation, cost of care, self-reported health-related quality of life and
depression.
Six month follow-up.
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Notes Included in previous systematic review and meta-analysis Clark 2007a.
Meta-analysis performed using number of patients randomised (n = 135).
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “After the baseline data were collected, the
nurse case manager opened a sealed enve-
lope with the random assignment. These
envelopes had been prepared by the project
director and attached to the numbered data
collection forms, to be opened in sequence”
p214.
Method of randomisation not detailed.
Allocation concealment? Yes See above.
Blinding?
Intervention
Yes “Wewere unable to strictly blind staff about
which patients were in the intervention
group, but a research assistant uninvolved
with the clinical care collected all follow-
up data” p214.
Incomplete outcome data addressed?
All outcomes
Yes For intervention arm, only 69 participants
were included in analysis as one outlier ex-
cluded from analysis.
“One outlier was removed from the data
set before analyses began because he spent
three months in the hospital while his fam-
ily debated taking him off life support”
p214.
Free of selective reporting? Yes Selective outcome reporting not evident.
Was the study powered to detect differences
in outcomes.?
Yes Sample size calculation performed. The
study was powered for the primary out-
come - HF readmission.
Were the study groups comparable at base-
line?
Unclear Comparison not made.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
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Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 406 non-Hispanic and Hispanic patients with documented systolic dysfunction.
Mean age 59 years.
54% of participants were male.
USA.
Interventions Structured telephone support.
An in-person appointment was arranged for each intervention patient, which included
symptom and disease education and referral to additional patient services (if required).
Follow-up telephone calls consisted of patient assessment, recording of admission infor-
mation reinforcement of self-monitoring and administration of a food-frequency ques-
tionnaire (at 2, 4, 8, 12 and 24 weeks and a report sent to patients). Intervention nurses
coordinated flow of information between patient and clinician and arranged medication
adjustment and required examinations.
Usual care patients received guidelines for managing systolic dysfunction, but no other
care information was specified.
Outcomes Mortality, hospitalisations, functional status (including quality of life).
12 month follow-up.
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “The project’s statistician used a computer-
generated, random-number
sequence without blocking or stratification
to centrally determine randomizations as-
signments and concealed treatment group
assignments in sealed, opaque envelopes”
p275.
Allocation concealment? Yes See above.
Blinding?
Intervention
Unclear To measure hospitalizations, we used
billing data from the 4 participating hos-
pitals. At quarterly telephone surveys, in-
terviewers who were blinded to treatment
assignment asked patients about hospital-
izations at nonparticipating hospitals; how-
ever, we present the analysis of billing data
because theymeasure hospitalizations inde-
pendent of possibly socially acceptable re-
sponses or survey non-response of the pa-
tients. p276.
89Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sisk 2006 (Continued)
Incomplete outcome data addressed?
All outcomes
Yes No losses to follow-up in the first 12
months of follow-up.
Free of selective reporting? Yes Selective outcome reporting not evident.
Was the study powered to detect differences
in outcomes.?
Yes Power calculation performed for sample
size - adequately powered for the primary
outcome of probability of hospitalisation.
Were the study groups comparable at base-
line?
Unclear Groups were similar.
Was the study reported according toCON-
SORT guidelines?
Unclear Reported according to CONSORT guide-
lines.
Was the diagnosis of heart failure defined
and appropriate?
Yes Systolic dysfunction on echo, etc.
Soran 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 315 patients with HF diagnosis secondary to systolic dysfunction (LVEF ≤ 40%).
Mean age 76 years.
35% of participants were male.
USA.
Interventions Telemonitoring.
Patients randomised to the Heart Failure Monitoring System (HFMS) cohort received
a disease management program using telecommunication equipment including an elec-
tronic scale and individualised symptom response system linked to a database staffed by
nurses. Patients weighed themselves and answered questions related to their heart failure.
Patients were contacted if any changes were observed in symptoms or weight.
Patients allocated to standard heart failure care (SC) received enhanced patient education,
education to clinicians and follow-up. They were provided with a digital home scale to
weigh themselves daily and educational materials related to worsening of HF and were
asked to record heart failure symptoms.
All patients were telephoned 30 days and 3 months post-randomisation for blinded
clinical data collection (vital signs, hospital visits, quality of life questionnaires).
Outcomes Treatment failure (cardiovascular mortality or rehospitalisation for HF within 6months)
, length of hospital stay, 6-month all-cause hospitalisation, 6-month heart failure hospi-
talisation, number of emergency room visits, Medicare expenditure, total patient costs,
quality of life.
Six month follow-up.
Notes Number of patients hospitalised calculated from reported%with any hospital admission.
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Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “...patients were randomised in a 1:1 ra-
tio..” p712.
Method of randomisation not detailed.
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Yes “Patients were also contacted by tele-
phone...by non-medical personnel masked
to treatment assignment to collect clinical
data...” p713.
“The trial used an independent adjudica-
tion event committee to classify deaths,
hospitalizations, and adverse events and
was monitored by an independent data sa-
fety monitoring board...” p712.
“The HFHC Trial was a multi centre,
randomised controlled clinical trial with
blinded endpoint evaluation...” p712.
Incomplete outcome data addressed?
All outcomes
Unclear “Eight patients refused to be re contacted
after randomisation and were considered
lost to follow-up” p713.
“The intention-to-treat principle was used
to compare HFMS to SC” p713.
Free of selective reporting? Yes No evidence of selective outcome report-
ing.
Was the study powered to detect differences
in outcomes.?
Yes Sample size calculation for the primary
endpoints was performed. Study was pow-
ered for these outcomes - (cardiovascular
death or rehospitalization; among patients
rehospitalisation for heart failure, length of
hospital stay was also considered a primary
end point).
Were the study groups comparable at base-
line?
Yes No statistically significant differences in the
variables reported.
Was the study reported according toCON-
SORT guidelines?
No Not reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Evidence of systolic dysfunction via a left
ventricular ejection fraction of <40% doc-
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umented by echocardiography, radionu-
clide ventriculography, or a contrast ven-
tricular angiogram; current symptoms of
heart failure including dyspnoea on ex-
ertion, orthopnoea, paroxysmal nocturnal
dyspnoea, fatigue, abdominal or lower ex-
tremity edema or swelling.
Tsuyuki 2004
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 276 patients discharged from hospital with heart failure.
Mean age 72 years.
58% of participants were male.
Canada.
Interventions Structured telephone support.
Early discharge planning with provision of adherence aids, patient education, regularly
scheduled telephone contact with local research coordinator at two and four weeks then
monthly thereafter for six months. Recommendations to see primary care physician if
not on target dose ACE inhibitor or deterioration.
Patients assigned to usual care received a general heart disease pamphlet before discharge,
but no formal counselling beyond what was routine at the hospital. Patients were con-
tacted monthly for six months to ascertain clinical events.
Outcomes Mortality, rehospitalisation, medication adherence, physician and emergency depart-
ment visits, cost-analysis.
6 month follow-up.
Notes Included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “Randomization was conducted by a com-
puter-generated sequence using block ran-
domisation (block size of 4), stratified by
study site (hospital)” p475.
Allocation concealment? Unclear ““...patients were randomised via a tele-
phone call to the project office” p475.
Blinding?
Intervention
Unclear Not detailed.
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Incomplete outcome data addressed?
All outcomes
Unclear Intervention: early withdrawal n = 5; lost
to follow-up n = 3.
Control: early withdrawal n = 2; lost to fol-
low-up n = 4.
Free of selective reporting? Yes Selective outcome reporting not evident.
Was the study powered to detect differences
in outcomes.?
Yes Sample size calculation performed. Study
was powered for the primary outcome -
medication adherence.
Were the study groups comparable at base-
line?
No Some variables differed between the
groups.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
Wakefield 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 148 patients hospitalised for HF exacerbation.
Mean age 69 years.
99% of participants were male.
USA.
Interventions Structured telephone support.
Patients allocated to the intervention group were allocated to 1 of 2 interventions: tele-
phone follow-up or videophone follow-up. Intervention patients were contacted by a
nurse 3 times in the first week then weekly for 11 weeks. Symptoms and the patients
discharge plan was reviewed and reinforced as well as referrals made if required. Addi-
tionally, the intervention nurses employed behaviour skill training strategies to maximise
self-management, self-monitoring and self-efficacy.
Usual care was not specified except to state that ”subjects contacted their primary care
nurse case manager by telephone if needed“.
Outcomes Mortality, readmissions, hospital days, time to first readmission, urgent care clinic visits,
quality of life, intervention dose and technical issues.
12 month follow-up.
Notes Telephone and videophone intervention arms were combined and classed as structured
telephone support.
Risk of bias
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Item Authors’ judgement Description
Adequate sequence generation? Yes ”The project coordinator prepared sealed
envelopes containing group assignments in
blocks of 24“ p754.
Allocation concealment? Yes ”Following informed consent and baseline
data collection, study nurses opened the en-
velope to assign subjects to one of three
treatment conditions: usual care, telephone
follow-up, or videophone follow-up” p754.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Yes “At 3 months, 85% (n = 126) completed
follow-up; at 6 months, 74% (n = 109)
completed follow-up” p757.
“All data analyses were conducted using an
intent-to-treat approach” p755.
Free of selective reporting? Yes Selective outcome reporting not evident.
Was the study powered to detect differences
in outcomes.?
No Power calculation performed to determine
sample size for readmission at 3 months.
Study not powered for this outcome.
Were the study groups comparable at base-
line?
Yes No statistically significant differences be-
tween groups at baseline.
Was the study reported according toCON-
SORT guidelines?
Yes Study reported according to CONSORT
guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Not detailed.
Woodend 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 121 patients with symptomatic heart failure (NYHA Class II or greater).
Mean age 68 years.
74% of participants were male.
Canada.
Interventions Telemonitoring.
Daily transmission of weight and periodic transmission of ECG and BP. Weekly video
conferences by tele-home care nurse. Video conferences more frequent in first few weeks
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and tapered over the 3 months.
Usual care was not described.
Outcomes Mortality, rehospitalisation, quality of life, emergency department visits, patient satis-
faction.
12 month follow-up.
Notes Mortality data included in previous systematic review and meta-analysis Clark 2007a.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Method of randomisation not detailed.
Allocation concealment? Unclear Not detailed.
Blinding?
Intervention
Unclear Not detailed.
Incomplete outcome data addressed?
All outcomes
Unclear Not detailed.
Free of selective reporting? No Some nominated outcomes not reported
(morbidity).
Was the study powered to detect differences
in outcomes.?
Unclear Sample size calculation not reported.
Were the study groups comparable at base-
line?
Yes The groups differed at baseline.
Was the study reported according toCON-
SORT guidelines?
No Study not reported according to CON-
SORT guidelines.
Was the diagnosis of heart failure defined
and appropriate?
Yes Symptomatic HF (New York Heart Asso-
ciation [NYHA] Class II or greater.
Zugck 2008 (HiTel)
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 88 patients recruited from hospital, mean LVEF was 24 ± 7%. Inclusion criteria NYHA
II-IV on optimum therapy and telephone at home.
Mean age 58.1 years.
82% of participants were male.
Germany.
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Interventions Telemonitoring.
Intervention group transmitted tomonitoring centre viamodem vital signs, BP SpO2and
received lifestyle and medication education. NYHA III and IV transmitted weekly and
NYHA II monthly. Medical advice was available 24/7.
Usual care not described.
Outcomes All cause hospitalisation.
Three month follow-up.
Notes Translated from German and English abstracts.
Authors provided further details.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “After screening all patients were ran-
domised with a standard procedure” - cor-
respondence from author.
Allocation concealment? No Unable to assess.
Blinding?
Intervention
Unclear Unable to assess.
Incomplete outcome data addressed?
All outcomes
Unclear Unable to assess.
Free of selective reporting? Unclear Unable to assess.
Was the study powered to detect differences
in outcomes.?
Unclear Unable to assess.
Were the study groups comparable at base-
line?
Unclear Unable to assess.
Was the study reported according toCON-
SORT guidelines?
Unclear Unable to assess.
Was the diagnosis of heart failure defined
and appropriate?
Unclear Unable to assess.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Akosah 2005 Contra to protocol: intervention included frequent clinic visits.
Albanese 2001 Contra to protocol: invasive impedence monitoring (SCOOP II Trial Evaluating CRT/ICD/Im-
pedence Monitoring).
Albert 2007 Contra to protocol: intervention was an education video.
Aliti 2007 Discussion paper.
Anderson 2005 Contra to protocol: intervention was a heart failure clinic.
Artinian 2003 Contra to protocol: web-based intervention, not an RCT.
Artinian 2006 Contra to protocol: intervention specific for hypertension, not heart failure.
Arya 2008 Contra to protocol: invasive haemodynamic monitoring.
Baden 2007a Contra to protcol: not an RCT.
Baden 2007b Contra to protocol: not an RCT.
Baer 1999 Asessment of correlation between electronic patient measurements and manual nurse measure-
ments.
Baldauf 2008 Contra to protocol: not an RCT.
Barber 1999 Contra to protocol: not an RCT, quasi experimental design.
Benatar 2003 Contra to protocol: comparison was between telemonitoring and home visits (not usual care).
Bennett 2006 Contra to protcol: intervention was a computer-based intervention.
Blue 2001 Contra to protocol: intervention included home visits.
Bocchi 2007 (REMADHE) Contra to protocol: intervention involved intensive group education sessions and face-to-face
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Brownsell 2006b Author contacted: primary and secondary outcomes for this review were not measured.
Brownsell 2008 Author contacted: primary and secondary outcomes for this review were not measured.
Caldwell 2005 Contra to protocol: education session with one follow-up telephone call.
Calvin 2008 Contra to protocol: participants received 18 education sessions aimed to develop self-management
skills. The intervention did not include telemonitoring or structured telephone support.
Capomolla 2002 Contra to protocol: intervention was a day hospital.
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Chetney 2003 Contra to protocol: not an RCT.
Chetney 2008 Contra to protocol: not an RCT.
Clappers 2006 Review of abstracts.
Clark 2008 Interviews with carers of patients with heart failure regarding their experiences.
Clarke 2005 Conference discussion paper.
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with follow up at an outpatient clinic.
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Dansky 2008a Contra to protocol: intervention included home visits.
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Foley 2008 Contra to protocol: not an RCT.
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Heidenreich 1999 Contra to protocol: not an RCT.
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Machingo 2003 Contra to protocol: not an RCT.
Maddukuri 2006 Contra to protocol: not an RCT.
Madigan 2008 Contra to protcol: not an RCT.
Maglaveras 2002 Contra to protocol:Not RCT
Maglaveras 2003 Contra to protocol: not an RCT
Maglaveras 2006 Contra to protocol: not an RCT
Mair 2007 Review paper.
Makaya 2008 Contra to protocol: intervention included home visits.
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Marangelli 2007 Contra to protocol: not an RCT.
Martensson 2005 Contra to protocol: intervention included home visits.
Mau 2006 Contra to protocol: intervention included home visits.
McCauley 2006 Contra to protocol: intervention included home visits.
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Myers 2006 Contra to protocol: not an RCT.
Nanevicz 2000 Contra to protocol: not an RCT.
Naylor 1999 Contra to protocol: intervention included home visits.
Naylor 2004 Contra to protocol: intervention included home visits.
Nguyen 2007 Contra to protocol: not an RCT.
Nobel 2003 Contra to protocol: not an RCT.
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Oddone 1999 Contra to protocol: not an RCT.
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Tramarin 2005 Collection of abstracts, not relating to structured telephone support or telemonitoring in heart
failure.
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Waywell 2007 Contra to protocol: not an RCT.
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Westlake 2007 Contra to protocol: intervention was web-based.
Wheeler 2006 Contra to protocol: intervention included home visits.
Whitten 2007 Review.
Wierzchowiecki 2005 Contra to protocol: intervention included home visits.
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Wongpiriyayothar 2008 Contra to protocol: intervention included home visits.
Wright 2003 Contra to protocol: intervention consisted of symptom diary, attended three education session and
clinic visits.
Wu 2006 Comparison of internet-based technology.
Zaphiriou 2006 Contra to protocol: intervention included a home visit.
Zentner 2007 Contra to protocol: not an RCT.
Zugck 2006 Contra to protocol: not an RCT.
Characteristics of studies awaiting assessment [ordered by study ID]
Dunlap 2006 (HearT-I)
Methods Randomised controlled trial; Intervention versus usual care
Participants 455 patients to date (NYHA Class II or greater).
Mean age no data.
% of participants were male - no data.
USA.
Interventions Structured Telephone Support
Three components; 10 computer initiated medication refill and clinic appointment reminders; 2) IVR access to
education modules 3) Computer initiated phone calls with a series of question regarding weight and symptom
Outcomes All cause hospitalisation; Unscheduled outpatient visits.
KCCQ; Satisfaction ; Adherence to medications; knowledge of self care and heart failure
12 months follow-up.
Notes Unable to contact authors to determine or clarify intervention and usual care arms
Levine2006(Mind My Heart)
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 234 patients
Mean age not reported.
% of participants were male- not reported.
USA.
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Levine2006(Mind My Heart) (Continued)
Interventions Telemonitoring.
Intervention group transmitted to monitoring centre via modem vital signs, BP SpO2.
Usual care no further contact with project staff.
Outcomes Technology use and Satisfaction Survey
Notes No primary outcomes reported. Unable to contact authors
Scherr 2005 (MobiTEL)
Methods Open randomised controlled trial; Intervention versus usual care
Participants 57 = 28 Telemonitoring / 29 Usual Care patients (NYHA Class II or greater).
Recruiting on-going at time of report
Mean age 63 years.
% of participants were male - no data.
Austria.
Interventions Telemonitoring
Mobile phone and digital weight scale; data transferred to telemonitoring centre
Outcomes Combined end-point of CVD mortality and CHF hospitalisation
NYHF Class; MLWHFQ; Cost Effectiveness
Six months follow-up.
Notes Published after census data of review. Primary outcomes only reported as combined outcomes
Yakushin 2006
Methods Randomised controlled trial; intervention arm and control (usual care) arm.
Participants 78 patients
Mean age 56 years.
% of participants were male-not reported.
Russian Federation.
Interventions Unable to determine intervention from abstract
Some telephone follow-up
Usual care not described.
Outcomes Hospitalisations and Cardiovascular death
Notes Unable to contact authors
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Characteristics of ongoing studies [ordered by study ID]
Chaudry 2007 (Tele-HF)
Trial name or title Telemonitoring to Improve Heart Failure (Tele-HF)
Methods Randomised control trial
Centralised randomisation performed by telephone stratified by study site and force randomised within each
study site in blocks of 20 (10 intervention: 10 control)
Power calculated for all-cause mortality and hospitalisation. 1640 participants (820 in each group)
Participants Discharged from a HF hospitalisation within 30 days of enrolment in the study
Exclusion < 18 years, No English or Spanish, < 6 months predicted survival
Interventions Telemonitoring
Participants made daily toll-free call to an automated telemonitoring system with pre-recorded surveys about
daily weight and symptoms (Pharos Innovations, Chicago)
Data downloads were viewed daily for variances and patients contacted by phone for follow-up
Usual Care Discharge follow-up with Physician and discussion of guidelines
Outcomes Follow-up 6 months
All cause morality
All cause re-admission
Starting date Study is now completed. Results due in approximately 12 months.
Contact information Dr Sarwat I Chaudhry , Yale University School of Medicine,
PO Box 208025 New Haven CT 06520-8025
Notes Final results not published
Kohler 2006
Trial name or title Partnership for the Heart -the Heart Coach System
Methods A randomised prospective multi-centre study
Participants 450 patients with chronic heart failure NYHA Function Class II-III
Interventions The German Federal Ministry of Econmics and Technology launched an invitation to tender for a telemoni-
toring platform system (ww.nextgenerationmedia.de). The total cost of the project is EURO8 million (grant
EURO4.9 million) The aim is to demonstrate the superiority of a telemedicine home care monitoring system.
Outcomes Primary endpoints Mortality, duration of inpatient treatment and costs.
Secondary Endpoints quality of life.
Starting date 2005-2008
Contact information Friedrich Köhler MD, Charite-Universitätsmedizin Berlin,
friedrich.koehler@charite.de
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Kohler 2006 (Continued)
Notes Awaiting contact from authors for further details or publications
Kulshreshtha 2008a
Trial name or title Remote Monitoring Program
Methods Randomised control trial
Participants 150 Eligible patients from Massachusetts General Hospital
Interventions Participants transmitted daily vital signs data and weight to a nurse who coordinated care with a physician.
Timely interventions and teaching were offered over the course of the 6 month study.
Outcomes All cause readmission
HF related admission mortality ER Visits and Lenght of Stay
Starting date 2008
Contact information Dr Ambar Kulshreshtha, Harvard Medical School, Boston MA
Notes Only abstract available. No response after several attempts to contact authors.
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D A T A A N D A N A L Y S E S
Comparison 1. Impact of structured telephone support and telemonitoring in CHF on all-cause mortality
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All-cause mortality (full
peer-reviewed publications
only): structured telephone
support vs usual care
15 5563 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.76, 1.01]
2 All-cause mortality (full
peer-reviewed publications
only): telemonitoring vs usual
care
11 2710 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.54, 0.81]
3 Sensitivity analysis (full
peer-reviewed publications and
abstracts): all-cause mortality:
structured telephone support vs
usual care
17 6676 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.84, 1.09]
4 Sensitivity analysis (full
peer-reviewed publications and
abstracts): all-cause mortality:
telemonitoring vs usual care
14 3079 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.57, 0.82]
5 Sensitivity analysis (full
peer-reviewed publications
only), follow-up period (>6
months), all-cause mortality:
structured telephone support vs
usual care
9 4292 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.74, 1.02]
6 Sensitivity analysis (full
peer-reviewed publications
only), follow-up period (>6
months), all-cause mortality:
telemonitoring vs usual care
8 1994 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.55, 0.86]
Comparison 2. Impact of structured telephone or telemonitoring in CHF on risk of all-cause hospitalisation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All-cause hospitalisation (full
peer-reviewed publications
only): structured telephone
support vs usual care
11 4295 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.85, 0.99]
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2 All-cause hospitalisation (full
peer-reviewed publications
only): telemonitoring vs usual
care
8 2343 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.84, 0.99]
3 Sensitivity analysis (full
peer-reviewed publications
and abstracts), all-cause
hospitalisation: structured
telephone support vs usual care
12 4700 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.84, 0.97]
4 Sensitivity analysis (full
peer-reviewed publications
and abstracts), all-cause
hospitalisation: telemonitoring
vs usual care
11 2712 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.87, 1.01]
5 Sensitivity analysis (full
peer-reviewed publications
only), follow-up period
(> 6 months), all-cause
hospitalisation: structured
telephone support vs usual care
6 3058 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.83, 0.99]
6 Sensitivity analysis (full
peer-reviewed publications
only), follow-up period
(> 6 months), all-cause
hospitalisation: telemonitoring
vs usual care
6 1748 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.80, 0.95]
Comparison 3. Impact of structured telephone support or telemonitoring in CHF on risk of CHF-related hospi-
talisation rate
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CHF-related hospitalisation
(full peer-reviewed publications
only): structured telephone
support vs usual care
13 4269 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.68, 0.87]
2 CHF-related hospitalisation
(full peer-reviewed publications
only): telemonitoring vs usual
care
4 1570 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.67, 0.94]
3 Sensitivity analysis (full
peer-reviewed publications
and abstracts), CHF-related
hospitalisation rate: structured
telephone support vs usual care
14 4674 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.68, 0.87]
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4 Sensitivity analysis (full
peer-reviewed publications
and abstracts), CHF-related
hospitalisation rate:
telemonitoring vs usual care
6 1735 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.64, 0.89]
5 Sensitivity analysis (full
peer-reviewed publications
only), follow-up period (>
6 months), CHF-related
hospitalisation: structured
telephone support vs usual care
6 2948 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.65, 0.89]
6 Sensitivity analysis (full
peer-reviewed publications
only), follow-up period (>
6 months), CHF-related
hospitalisation: telemonitoring
vs usual care
4 1570 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.67, 0.94]
Analysis 1.1. Comparison 1 Impact of structured telephone support and telemonitoring in CHF on all-cause
mortality, Outcome 1 All-cause mortality (full peer-reviewed publications only): structured telephone support
vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in CHF on all-cause mortality
Outcome: 1 All-cause mortality (full peer-reviewed publications only): structured telephone support vs usual care
Study or subgroup Intervention Usual Care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Barth 2001 0/17 0/17 0.0 [ 0.0, 0.0 ]
Cleland 2005(Struct Tele) 27/173 20/85 0.66 [ 0.40, 1.11 ]
DeBusk 2004 21/228 29/234 0.74 [ 0.44, 1.26 ]
DeWalt 2006 3/62 4/65 0.79 [ 0.18, 3.37 ]
Galbreath 2004 54/710 39/359 0.70 [ 0.47, 1.04 ]
Gattis 1999 (PHARM) 3/90 5/91 0.61 [ 0.15, 2.46 ]
GESICA 2005 (DIAL) 116/760 122/758 0.95 [ 0.75, 1.20 ]
Laramee 2003 13/141 15/146 0.90 [ 0.44, 1.82 ]
Mortara 2009 (Struct Tele) 9/106 9/160 1.51 [ 0.62, 3.68 ]
Rainville 1999 1/19 4/19 0.25 [ 0.03, 2.04 ]
Riegel 2002 16/130 32/228 0.88 [ 0.50, 1.54 ]
0.01 0.1 1 10 100
Favours experimental Favours control
(Continued . . . )
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(. . . Continued)
Study or subgroup Intervention Usual Care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Riegel 2006 6/70 8/65 0.70 [ 0.26, 1.90 ]
Sisk 2006 22/203 22/203 1.00 [ 0.57, 1.75 ]
Tsuyuki 2004 16/140 12/136 1.30 [ 0.64, 2.64 ]
Wakefield 2008 25/99 11/49 1.12 [ 0.60, 2.09 ]
Total (95% CI) 2948 2615 0.88 [ 0.76, 1.01 ]
Total events: 332 (Intervention), 332 (Usual Care)
Heterogeneity: Chi2 = 8.48, df = 13 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.78 (P = 0.076)
0.01 0.1 1 10 100
Favours experimental Favours control
Analysis 1.2. Comparison 1 Impact of structured telephone support and telemonitoring in CHF on all-cause
mortality, Outcome 2 All-cause mortality (full peer-reviewed publications only): telemonitoring vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in CHF on all-cause mortality
Outcome: 2 All-cause mortality (full peer-reviewed publications only): telemonitoring vs usual care
Study or subgroup Intervention Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 3/28 5/29 2.4 % 0.62 [ 0.16, 2.36 ]
Balk 2008 9/101 8/113 3.6 % 1.26 [ 0.50, 3.14 ]
Capomolla 2004 5/67 7/66 3.4 % 0.70 [ 0.24, 2.11 ]
Cleland 2005 (Telemon) 28/168 20/85 12.8 % 0.71 [ 0.42, 1.18 ]
de Lusignan 2001 2/10 3/10 1.4 % 0.67 [ 0.14, 3.17 ]
Giordano 2009 21/230 32/230 15.5 % 0.66 [ 0.39, 1.10 ]
Goldberg 2003 (WHARF) 11/138 26/142 12.4 % 0.44 [ 0.22, 0.85 ]
Kielblock 2007 37/251 69/251 33.3 % 0.54 [ 0.37, 0.77 ]
Mortara 2009 (Telemon) 15/195 9/160 4.8 % 1.37 [ 0.61, 3.04 ]
Soran 2008 11/160 17/155 8.3 % 0.63 [ 0.30, 1.29 ]
0.01 0.1 1 10 100
Favours experimental Favours control
(Continued . . . )
114Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Intervention Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Woodend 2008 5/62 4/59 2.0 % 1.19 [ 0.34, 4.22 ]
Total (95% CI) 1410 1300 100.0 % 0.66 [ 0.54, 0.81 ]
Total events: 147 (Intervention), 200 (Usual Care)
Heterogeneity: Chi2 = 8.84, df = 10 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 4.07 (P = 0.000046)
0.01 0.1 1 10 100
Favours experimental Favours control
Analysis 1.3. Comparison 1 Impact of structured telephone support and telemonitoring in CHF on all-cause
mortality, Outcome 3 Sensitivity analysis (full peer-reviewed publications and abstracts): all-cause mortality:
structured telephone support vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in CHF on all-cause mortality
Outcome: 3 Sensitivity analysis (full peer-reviewed publications and abstracts): all-cause mortality: structured telephone support vs usual care
Study or subgroup Intervention Usual Care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2007 51/360 28/348 1.76 [ 1.14, 2.73 ]
Barth 2001 0/17 0/17 0.0 [ 0.0, 0.0 ]
Cleland 2005(Struct Tele) 27/173 20/85 0.66 [ 0.40, 1.11 ]
DeBusk 2004 21/228 29/234 0.74 [ 0.44, 1.26 ]
DeWalt 2006 3/62 4/65 0.79 [ 0.18, 3.37 ]
Galbreath 2004 54/710 39/359 0.70 [ 0.47, 1.04 ]
Gattis 1999 (PHARM) 3/90 5/91 0.61 [ 0.15, 2.46 ]
GESICA 2005 (DIAL) 116/760 122/758 0.95 [ 0.75, 1.20 ]
Krum 2009 (CHAT) 17/188 16/217 1.23 [ 0.64, 2.36 ]
Laramee 2003 13/141 15/146 0.90 [ 0.44, 1.82 ]
Mortara 2009 (Struct Tele) 9/106 9/160 1.51 [ 0.62, 3.68 ]
Rainville 1999 1/19 4/19 0.25 [ 0.03, 2.04 ]
Riegel 2002 16/130 32/228 0.88 [ 0.50, 1.54 ]
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Study or subgroup Intervention Usual Care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Riegel 2006 6/70 8/65 0.70 [ 0.26, 1.90 ]
Sisk 2006 22/203 22/203 1.00 [ 0.57, 1.75 ]
Tsuyuki 2004 16/140 12/136 1.30 [ 0.64, 2.64 ]
Wakefield 2008 25/99 11/49 1.12 [ 0.60, 2.09 ]
Total (95% CI) 3496 3180 0.96 [ 0.84, 1.09 ]
Total events: 400 (Intervention), 376 (Usual Care)
Heterogeneity: Chi2 = 17.84, df = 15 (P = 0.27); I2 =16%
Test for overall effect: Z = 0.66 (P = 0.51)
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Analysis 1.4. Comparison 1 Impact of structured telephone support and telemonitoring in CHF on all-cause
mortality, Outcome 4 Sensitivity analysis (full peer-reviewed publications and abstracts): all-cause mortality:
telemonitoring vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in CHF on all-cause mortality
Outcome: 4 Sensitivity analysis (full peer-reviewed publications and abstracts): all-cause mortality: telemonitoring vs usual care
Study or subgroup Intervention Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 3/28 5/29 2.1 % 0.62 [ 0.16, 2.36 ]
Balk 2008 9/101 8/113 3.2 % 1.26 [ 0.50, 3.14 ]
Blum 2007 (MCCD) 17/102 21/102 8.9 % 0.81 [ 0.45, 1.44 ]
Capomolla 2004 5/67 7/66 3.0 % 0.70 [ 0.24, 2.11 ]
Cleland 2005 (Telemon) 28/168 20/85 11.2 % 0.71 [ 0.42, 1.18 ]
de Lusignan 2001 2/10 3/10 1.3 % 0.67 [ 0.14, 3.17 ]
Giordano 2009 21/230 32/230 13.5 % 0.66 [ 0.39, 1.10 ]
Goldberg 2003 (WHARF) 11/138 26/142 10.8 % 0.44 [ 0.22, 0.85 ]
Kielblock 2007 37/251 69/251 29.1 % 0.54 [ 0.37, 0.77 ]
Mortara 2009 (Telemon) 15/195 9/160 4.2 % 1.37 [ 0.61, 3.04 ]
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Study or subgroup Intervention Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Parati 2009 (ICAROS) 5/33 9/44 3.3 % 0.74 [ 0.27, 2.00 ]
Soran 2008 11/160 17/155 7.3 % 0.63 [ 0.30, 1.29 ]
Woodend 2008 5/62 4/59 1.7 % 1.19 [ 0.34, 4.22 ]
Zugck 2008 (HiTel) 3/58 1/30 0.6 % 1.55 [ 0.17, 14.28 ]
Total (95% CI) 1603 1476 100.0 % 0.68 [ 0.57, 0.82 ]
Total events: 172 (Intervention), 231 (Usual Care)
Heterogeneity: Chi2 = 9.86, df = 13 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 4.08 (P = 0.000046)
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Analysis 1.5. Comparison 1 Impact of structured telephone support and telemonitoring in CHF on all-cause
mortality, Outcome 5 Sensitivity analysis (full peer-reviewed publications only), follow-up period (>6 months),
all-cause mortality: structured telephone support vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in CHF on all-cause mortality
Outcome: 5 Sensitivity analysis (full peer-reviewed publications only), follow-up period (>6 months), all-cause mortality: structured telephone support vs usual care
Study or subgroup Intervention Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005(Struct Tele) 27/173 20/85 9.5 % 0.66 [ 0.40, 1.11 ]
DeBusk 2004 21/228 29/234 10.2 % 0.74 [ 0.44, 1.26 ]
DeWalt 2006 3/62 4/65 1.4 % 0.79 [ 0.18, 3.37 ]
Galbreath 2004 54/710 39/359 18.4 % 0.70 [ 0.47, 1.04 ]
GESICA 2005 (DIAL) 116/760 122/758 43.4 % 0.95 [ 0.75, 1.20 ]
Mortara 2009 (Struct Tele) 9/106 9/160 2.6 % 1.51 [ 0.62, 3.68 ]
Rainville 1999 1/19 4/19 1.4 % 0.25 [ 0.03, 2.04 ]
Sisk 2006 22/203 22/203 7.8 % 1.00 [ 0.57, 1.75 ]
Wakefield 2008 25/99 11/49 5.2 % 1.12 [ 0.60, 2.09 ]
Total (95% CI) 2360 1932 100.0 % 0.87 [ 0.74, 1.02 ]
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Study or subgroup Intervention Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 278 (Intervention), 260 (Usual Care)
Heterogeneity: Chi2 = 6.85, df = 8 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 1.73 (P = 0.083)
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Analysis 1.6. Comparison 1 Impact of structured telephone support and telemonitoring in CHF on all-cause
mortality, Outcome 6 Sensitivity analysis (full peer-reviewed publications only), follow-up period (>6 months),
all-cause mortality: telemonitoring vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in CHF on all-cause mortality
Outcome: 6 Sensitivity analysis (full peer-reviewed publications only), follow-up period (>6 months), all-cause mortality: telemonitoring vs usual care
Study or subgroup Intervention Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 3/28 5/29 3.1 % 0.62 [ 0.16, 2.36 ]
Balk 2008 9/101 8/113 4.7 % 1.26 [ 0.50, 3.14 ]
Capomolla 2004 5/67 7/66 4.4 % 0.70 [ 0.24, 2.11 ]
Cleland 2005 (Telemon) 28/168 20/85 16.6 % 0.71 [ 0.42, 1.18 ]
de Lusignan 2001 2/10 3/10 1.9 % 0.67 [ 0.14, 3.17 ]
Giordano 2009 21/230 32/230 20.0 % 0.66 [ 0.39, 1.10 ]
Kielblock 2007 37/251 69/251 43.1 % 0.54 [ 0.37, 0.77 ]
Mortara 2009 (Telemon) 15/195 9/160 6.2 % 1.37 [ 0.61, 3.04 ]
Total (95% CI) 1050 944 100.0 % 0.69 [ 0.55, 0.86 ]
Total events: 120 (Intervention), 153 (Usual Care)
Heterogeneity: Chi2 = 6.43, df = 7 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 3.31 (P = 0.00093)
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Analysis 2.1. Comparison 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause
hospitalisation, Outcome 1 All-cause hospitalisation (full peer-reviewed publications only): structured
telephone support vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause hospitalisation
Outcome: 1 All-cause hospitalisation (full peer-reviewed publications only): structured telephone support vs usual care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005(Struct Tele) 85/173 46/85 7.1 % 0.91 [ 0.71, 1.16 ]
DeBusk 2004 116/228 117/234 13.2 % 1.02 [ 0.85, 1.22 ]
Gattis 1999 (PHARM) 17/90 30/91 3.4 % 0.57 [ 0.34, 0.96 ]
GESICA 2005 (DIAL) 261/760 296/758 34.0 % 0.88 [ 0.77, 1.00 ]
Laramee 2003 49/141 46/146 5.2 % 1.10 [ 0.79, 1.53 ]
Mortara 2009 (Struct Tele) 37/106 48/160 4.4 % 1.16 [ 0.82, 1.65 ]
Riegel 2002 56/130 114/228 9.5 % 0.86 [ 0.68, 1.09 ]
Riegel 2006 39/70 37/65 4.4 % 0.98 [ 0.73, 1.32 ]
Sisk 2006 62/203 74/203 8.5 % 0.84 [ 0.64, 1.10 ]
Tsuyuki 2004 59/140 51/136 5.9 % 1.12 [ 0.84, 1.50 ]
Wakefield 2008 41/99 29/49 4.4 % 0.70 [ 0.50, 0.97 ]
Total (95% CI) 2140 2155 100.0 % 0.92 [ 0.85, 0.99 ]
Total events: 822 (Intervention), 888 (Control)
Heterogeneity: Chi2 = 13.09, df = 10 (P = 0.22); I2 =24%
Test for overall effect: Z = 2.25 (P = 0.024)
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Analysis 2.2. Comparison 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause
hospitalisation, Outcome 2 All-cause hospitalisation (full peer-reviewed publications only): telemonitoring vs
usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause hospitalisation
Outcome: 2 All-cause hospitalisation (full peer-reviewed publications only): telemonitoring vs usual care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 9/28 26/29 4.3 % 0.36 [ 0.21, 0.62 ]
Cleland 2005 (Telemon) 80/168 46/85 10.2 % 0.88 [ 0.68, 1.13 ]
Giordano 2009 67/230 96/230 16.0 % 0.70 [ 0.54, 0.90 ]
Goldberg 2003 (WHARF) 65/138 67/142 11.0 % 1.00 [ 0.78, 1.28 ]
Kielblock 2007 157/251 176/251 29.3 % 0.89 [ 0.79, 1.01 ]
Mortara 2009 (Telemon) 69/195 48/160 8.8 % 1.18 [ 0.87, 1.60 ]
Soran 2008 75/160 66/155 11.2 % 1.10 [ 0.86, 1.41 ]
Woodend 2008 60/62 54/59 9.2 % 1.06 [ 0.97, 1.16 ]
Total (95% CI) 1232 1111 100.0 % 0.91 [ 0.84, 0.99 ]
Total events: 582 (Intervention), 579 (Control)
Heterogeneity: Chi2 = 31.30, df = 7 (P = 0.00005); I2 =78%
Test for overall effect: Z = 2.29 (P = 0.022)
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Analysis 2.3. Comparison 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause
hospitalisation, Outcome 3 Sensitivity analysis (full peer-reviewed publications and abstracts), all-cause
hospitalisation: structured telephone support vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause hospitalisation
Outcome: 3 Sensitivity analysis (full peer-reviewed publications and abstracts), all-cause hospitalisation: structured telephone support vs usual care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005(Struct Tele) 85/173 46/85 6.3 % 0.91 [ 0.71, 1.16 ]
DeBusk 2004 116/228 117/234 11.8 % 1.02 [ 0.85, 1.22 ]
Gattis 1999 (PHARM) 17/90 30/91 3.0 % 0.57 [ 0.34, 0.96 ]
GESICA 2005 (DIAL) 261/760 296/758 30.3 % 0.88 [ 0.77, 1.00 ]
Krum 2009 (CHAT) 74/188 114/217 10.8 % 0.75 [ 0.60, 0.93 ]
Laramee 2003 49/141 46/146 4.6 % 1.10 [ 0.79, 1.53 ]
Mortara 2009 (Struct Tele) 37/106 48/160 3.9 % 1.16 [ 0.82, 1.65 ]
Riegel 2002 56/130 114/228 8.5 % 0.86 [ 0.68, 1.09 ]
Riegel 2006 39/70 37/65 3.9 % 0.98 [ 0.73, 1.32 ]
Sisk 2006 62/203 74/203 7.6 % 0.84 [ 0.64, 1.10 ]
Tsuyuki 2004 59/140 51/136 5.3 % 1.12 [ 0.84, 1.50 ]
Wakefield 2008 41/99 29/49 4.0 % 0.70 [ 0.50, 0.97 ]
Total (95% CI) 2328 2372 100.0 % 0.90 [ 0.84, 0.97 ]
Total events: 896 (Intervention), 1002 (Control)
Heterogeneity: Chi2 = 16.20, df = 11 (P = 0.13); I2 =32%
Test for overall effect: Z = 2.95 (P = 0.0032)
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Analysis 2.4. Comparison 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause
hospitalisation, Outcome 4 Sensitivity analysis (full peer-reviewed publications and abstracts), all-cause
hospitalisation: telemonitoring vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause hospitalisation
Outcome: 4 Sensitivity analysis (full peer-reviewed publications and abstracts), all-cause hospitalisation: telemonitoring vs usual care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 9/28 26/29 3.8 % 0.36 [ 0.21, 0.62 ]
Blum 2007 (MCCD) 42/102 28/102 4.2 % 1.50 [ 1.01, 2.22 ]
Cleland 2005 (Telemon) 80/168 46/85 9.1 % 0.88 [ 0.68, 1.13 ]
Giordano 2009 67/230 96/230 14.2 % 0.70 [ 0.54, 0.90 ]
Goldberg 2003 (WHARF) 65/138 67/142 9.8 % 1.00 [ 0.78, 1.28 ]
Kielblock 2007 157/251 176/251 26.1 % 0.89 [ 0.79, 1.01 ]
Mortara 2009 (Telemon) 69/195 48/160 7.8 % 1.18 [ 0.87, 1.60 ]
Parati 2009 (ICAROS) 23/33 28/44 3.6 % 1.10 [ 0.80, 1.50 ]
Soran 2008 75/160 66/155 9.9 % 1.10 [ 0.86, 1.41 ]
Woodend 2008 60/62 54/59 8.2 % 1.06 [ 0.97, 1.16 ]
Zugck 2008 (HiTel) 24/58 17/30 3.3 % 0.73 [ 0.47, 1.13 ]
Total (95% CI) 1425 1287 100.0 % 0.94 [ 0.87, 1.01 ]
Total events: 671 (Intervention), 652 (Control)
Heterogeneity: Chi2 = 36.39, df = 10 (P = 0.00007); I2 =73%
Test for overall effect: Z = 1.71 (P = 0.087)
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Analysis 2.5. Comparison 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause
hospitalisation, Outcome 5 Sensitivity analysis (full peer-reviewed publications only), follow-up period (> 6
months), all-cause hospitalisation: structured telephone support vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause hospitalisation
Outcome: 5 Sensitivity analysis (full peer-reviewed publications only), follow-up period (> 6 months), all-cause hospitalisation: structured telephone support vs usual
care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005(Struct Tele) 85/173 46/85 9.9 % 0.91 [ 0.71, 1.16 ]
DeBusk 2004 116/228 117/234 18.5 % 1.02 [ 0.85, 1.22 ]
GESICA 2005 (DIAL) 261/760 296/758 47.5 % 0.88 [ 0.77, 1.00 ]
Mortara 2009 (Struct Tele) 37/106 48/160 6.1 % 1.16 [ 0.82, 1.65 ]
Sisk 2006 62/203 74/203 11.8 % 0.84 [ 0.64, 1.10 ]
Wakefield 2008 41/99 29/49 6.2 % 0.70 [ 0.50, 0.97 ]
Total (95% CI) 1569 1489 100.0 % 0.91 [ 0.83, 0.99 ]
Total events: 602 (Intervention), 610 (Control)
Heterogeneity: Chi2 = 6.38, df = 5 (P = 0.27); I2 =22%
Test for overall effect: Z = 2.15 (P = 0.032)
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Analysis 2.6. Comparison 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause
hospitalisation, Outcome 6 Sensitivity analysis (full peer-reviewed publications only), follow-up period (> 6
months), all-cause hospitalisation: telemonitoring vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in CHF on risk of all-cause hospitalisation
Outcome: 6 Sensitivity analysis (full peer-reviewed publications only), follow-up period (> 6 months), all-cause hospitalisation: telemonitoring vs usual care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 9/28 26/29 5.5 % 0.36 [ 0.21, 0.62 ]
Cleland 2005 (Telemon) 80/168 46/85 13.1 % 0.88 [ 0.68, 1.13 ]
Giordano 2009 67/230 96/230 20.6 % 0.70 [ 0.54, 0.90 ]
Kielblock 2007 157/251 176/251 37.7 % 0.89 [ 0.79, 1.01 ]
Mortara 2009 (Telemon) 69/195 48/160 11.3 % 1.18 [ 0.87, 1.60 ]
Woodend 2008 60/62 54/59 11.9 % 1.06 [ 0.97, 1.16 ]
Total (95% CI) 934 814 100.0 % 0.87 [ 0.80, 0.95 ]
Total events: 442 (Intervention), 446 (Control)
Heterogeneity: Chi2 = 34.23, df = 5 (P<0.00001); I2 =85%
Test for overall effect: Z = 3.04 (P = 0.0024)
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Analysis 3.1. Comparison 3 Impact of structured telephone support or telemonitoring in CHF on risk of
CHF-related hospitalisation rate, Outcome 1 CHF-related hospitalisation (full peer-reviewed publications
only): structured telephone support vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in CHF on risk of CHF-related hospitalisation rate
Outcome: 1 CHF-related hospitalisation (full peer-reviewed publications only): structured telephone support vs usual care
Study or subgroup Intervention Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Barth 2001 0/17 0/17 0.0 [ 0.0, 0.0 ]
Cleland 2005(Struct Tele) 34/173 24/85 0.70 [ 0.44, 1.10 ]
DeBusk 2004 38/228 43/234 0.91 [ 0.61, 1.35 ]
Gattis 1999 (PHARM) 1/90 11/91 0.09 [ 0.01, 0.70 ]
GESICA 2005 (DIAL) 128/760 169/758 0.76 [ 0.61, 0.93 ]
Laramee 2003 18/141 21/146 0.89 [ 0.49, 1.59 ]
Mortara 2009 (Struct Tele) 18/106 28/160 0.97 [ 0.57, 1.66 ]
Rainville 1999 4/19 10/19 0.40 [ 0.15, 1.05 ]
Ramachandran 2007 6/25 4/25 1.50 [ 0.48, 4.68 ]
Riegel 2002 23/130 63/228 0.64 [ 0.42, 0.98 ]
Riegel 2006 21/70 22/65 0.89 [ 0.54, 1.45 ]
Sisk 2006 18/203 29/203 0.62 [ 0.36, 1.08 ]
Tsuyuki 2004 37/140 38/136 0.95 [ 0.64, 1.39 ]
Total (95% CI) 2102 2167 0.77 [ 0.68, 0.87 ]
Total events: 346 (Intervention), 462 (Control)
Heterogeneity: Chi2 = 11.84, df = 11 (P = 0.38); I2 =7%
Test for overall effect: Z = 4.12 (P = 0.000037)
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Analysis 3.2. Comparison 3 Impact of structured telephone support or telemonitoring in CHF on risk of
CHF-related hospitalisation rate, Outcome 2 CHF-related hospitalisation (full peer-reviewed publications
only): telemonitoring vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in CHF on risk of CHF-related hospitalisation rate
Outcome: 2 CHF-related hospitalisation (full peer-reviewed publications only): telemonitoring vs usual care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Telemon) 40/168 24/85 14.6 % 0.84 [ 0.55, 1.30 ]
Giordano 2009 43/230 73/230 33.5 % 0.59 [ 0.42, 0.82 ]
Kielblock 2007 71/251 82/251 37.7 % 0.87 [ 0.66, 1.13 ]
Mortara 2009 (Telemon) 35/195 28/160 14.1 % 1.03 [ 0.65, 1.61 ]
Total (95% CI) 844 726 100.0 % 0.79 [ 0.67, 0.94 ]
Total events: 189 (Intervention), 207 (Control)
Heterogeneity: Chi2 = 4.88, df = 3 (P = 0.18); I2 =39%
Test for overall effect: Z = 2.66 (P = 0.0079)
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Analysis 3.3. Comparison 3 Impact of structured telephone support or telemonitoring in CHF on risk of
CHF-related hospitalisation rate, Outcome 3 Sensitivity analysis (full peer-reviewed publications and
abstracts), CHF-related hospitalisation rate: structured telephone support vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in CHF on risk of CHF-related hospitalisation rate
Outcome: 3 Sensitivity analysis (full peer-reviewed publications and abstracts), CHF-related hospitalisation rate: structured telephone support vs usual care
Study or subgroup Intervention Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Barth 2001 0/17 0/17 0.0 [ 0.0, 0.0 ]
Cleland 2005(Struct Tele) 34/173 24/85 0.70 [ 0.44, 1.10 ]
DeBusk 2004 38/228 43/234 0.91 [ 0.61, 1.35 ]
Gattis 1999 (PHARM) 1/90 11/91 0.09 [ 0.01, 0.70 ]
GESICA 2005 (DIAL) 128/760 169/758 0.76 [ 0.61, 0.93 ]
Krum 2009 (CHAT) 23/188 35/217 0.76 [ 0.47, 1.24 ]
Laramee 2003 18/141 21/146 0.89 [ 0.49, 1.59 ]
Mortara 2009 (Struct Tele) 18/106 28/160 0.97 [ 0.57, 1.66 ]
Rainville 1999 4/19 10/19 0.40 [ 0.15, 1.05 ]
Ramachandran 2007 6/25 4/25 1.50 [ 0.48, 4.68 ]
Riegel 2002 23/130 63/228 0.64 [ 0.42, 0.98 ]
Riegel 2006 21/70 22/65 0.89 [ 0.54, 1.45 ]
Sisk 2006 18/203 29/203 0.62 [ 0.36, 1.08 ]
Tsuyuki 2004 37/140 38/136 0.95 [ 0.64, 1.39 ]
Total (95% CI) 2290 2384 0.77 [ 0.68, 0.87 ]
Total events: 369 (Intervention), 497 (Control)
Heterogeneity: Chi2 = 11.85, df = 12 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 4.27 (P = 0.000020)
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Analysis 3.4. Comparison 3 Impact of structured telephone support or telemonitoring in CHF on risk of
CHF-related hospitalisation rate, Outcome 4 Sensitivity analysis (full peer-reviewed publications and
abstracts), CHF-related hospitalisation rate: telemonitoring vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in CHF on risk of CHF-related hospitalisation rate
Outcome: 4 Sensitivity analysis (full peer-reviewed publications and abstracts), CHF-related hospitalisation rate: telemonitoring vs usual care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Telemon) 40/168 24/85 12.6 % 0.84 [ 0.55, 1.30 ]
Giordano 2009 43/230 73/230 28.8 % 0.59 [ 0.42, 0.82 ]
Kielblock 2007 71/251 82/251 32.4 % 0.87 [ 0.66, 1.13 ]
Mortara 2009 (Telemon) 35/195 28/160 12.1 % 1.03 [ 0.65, 1.61 ]
Parati 2009 (ICAROS) 6/33 17/44 5.8 % 0.47 [ 0.21, 1.06 ]
Zugck 2008 (HiTel) 18/58 16/30 8.3 % 0.58 [ 0.35, 0.97 ]
Total (95% CI) 935 800 100.0 % 0.76 [ 0.64, 0.89 ]
Total events: 213 (Intervention), 240 (Control)
Heterogeneity: Chi2 = 7.53, df = 5 (P = 0.18); I2 =34%
Test for overall effect: Z = 3.42 (P = 0.00062)
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 3.5. Comparison 3 Impact of structured telephone support or telemonitoring in CHF on risk of
CHF-related hospitalisation rate, Outcome 5 Sensitivity analysis (full peer-reviewed publications only), follow-
up period (> 6 months), CHF-related hospitalisation: structured telephone support vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in CHF on risk of CHF-related hospitalisation rate
Outcome: 5 Sensitivity analysis (full peer-reviewed publications only), follow-up period (> 6 months), CHF-related hospitalisation: structured telephone support vs usual
care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005(Struct Tele) 34/173 24/85 10.5 % 0.70 [ 0.44, 1.10 ]
DeBusk 2004 38/228 43/234 13.9 % 0.91 [ 0.61, 1.35 ]
GESICA 2005 (DIAL) 128/760 169/758 55.5 % 0.76 [ 0.61, 0.93 ]
Mortara 2009 (Struct Tele) 18/106 28/160 7.3 % 0.97 [ 0.57, 1.66 ]
Rainville 1999 4/19 10/19 3.3 % 0.40 [ 0.15, 1.05 ]
Sisk 2006 18/203 29/203 9.5 % 0.62 [ 0.36, 1.08 ]
Total (95% CI) 1489 1459 100.0 % 0.76 [ 0.65, 0.89 ]
Total events: 240 (Intervention), 303 (Control)
Heterogeneity: Chi2 = 3.90, df = 5 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 3.48 (P = 0.00049)
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 3.6. Comparison 3 Impact of structured telephone support or telemonitoring in CHF on risk of
CHF-related hospitalisation rate, Outcome 6 Sensitivity analysis (full peer-reviewed publications only), follow-
up period (> 6 months), CHF-related hospitalisation: telemonitoring vs usual care.
Review: Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in CHF on risk of CHF-related hospitalisation rate
Outcome: 6 Sensitivity analysis (full peer-reviewed publications only), follow-up period (> 6 months), CHF-related hospitalisation: telemonitoring vs usual care
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Telemon) 40/168 24/85 14.6 % 0.84 [ 0.55, 1.30 ]
Giordano 2009 43/230 73/230 33.5 % 0.59 [ 0.42, 0.82 ]
Kielblock 2007 71/251 82/251 37.7 % 0.87 [ 0.66, 1.13 ]
Mortara 2009 (Telemon) 35/195 28/160 14.1 % 1.03 [ 0.65, 1.61 ]
Total (95% CI) 844 726 100.0 % 0.79 [ 0.67, 0.94 ]
Total events: 189 (Intervention), 207 (Control)
Heterogeneity: Chi2 = 4.88, df = 3 (P = 0.18); I2 =39%
Test for overall effect: Z = 2.66 (P = 0.0079)
0.01 0.1 1 10 100
Favours experimental Favours control
A P P E N D I C E S
Appendix 1. Search strategies
Cochrane Central Register of Controlled Trials (CENTRAL), Database of Abstracts of Reviews of Effects
(DARE) and Health Technology Assessment Database (HTA) on The Cochrane Library
#1 MeSH descriptor Heart Failure explode all trees
#2 heart next failure in All Text
#3 cardiac next failure in All Text
#4 (#1 or #2 or #3)
#5 MeSH descriptor telemedicine explode all trees
#6 MeSH descriptor telecommunications explode all trees
#7 MeSH descriptor case management this term only
#8 MeSH descriptor comprehensive health care explode all trees
#9 MeSH descriptor disease management this term only
#10 MeSH descriptor home care services this term only
#11 MeSH descriptor Home Care Services, Hospital-Based this term only
#12 MeSH descriptor Nurse Clinicians this term only
#13 MeSH descriptor nurse practitioners this term only
#14 MeSH descriptor monitoring, ambulatory this term only
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#15 MeSH descriptor clinical protocols this term only
#16 MeSH descriptor patient care planning this term only
#17 tele* in All Text
#18 (remote in All Text near/3 consult* in All Text)
#19 disease next management in All Text
#20 nurse next led in All Text
#21 phone* in All Text
#22 (manage* in All Text near/3 program* in All Text)
#23 (nurse* in All Text near/3 manage* in All Text)
#24 case next management in All Text
#25 (home in All Text near/3 service* in All Text) 7
#26 nurse next practitioner* in All Text
#27 nurse next clinician* in All Text
#28 care next plan* in All Text
#29 (#5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13)
#30 (#14 or #15 or #16 or #17 or #18 or #19 or #20 or #21)
#31 (#22 or #23 or #24 or #25 or #26 or #27 or #28)
#32 (#29 or #30 or #31)
#33 (#4 and #32)
Medline and Medline In Process on Ovid
1 exp Heart Failure/
2 heart failure.tw.
3 cardiac failure.tw.
4 or/1-3
5 exp Telemedicine/
6 exp Telecommunications/
7 Case Management/
8 exp Comprehensive Health Care/
9 disease management/
10 tele med$.tw.
11 telecare$.tw.
12 telecardiol$.tw.
13 telemonitor$.tw.
14 teleconsult$.tw.
15 teleconferenc$.tw.
16 telecommunicat$.tw.
17 telephon$.tw.
18 telehealth$.tw.
19 telemetry.tw.
20 (remote$ adj3 consult$).tw.
21 tele-med$.tw.
22 tele-consult$.tw.
23 tele-conferenc$.tw.
24 tele-health$.tw.
25 Home Care Services/
26 Home Care Services, Hospital-Based/
27 disease management.tw.
28 Nurse Clinicians/
29 Nurse Practitioners/
30 nurse led.tw.
31 Monitoring, Ambulatory/
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32 telehome.tw.
33 tele-home.tw.
34 phone$.tw.
35 Clinical Protocols/
36 Patient Care Planning/
37 or/5-36
38 37 and 4
39 randomized controlled trial.pt.
40 controlled clinical trial.pt.
41 Randomized controlled trials/
42 random allocation/
43 double blind method/
44 single-blind method/
45 or/39-44
46 exp animal/ not humans/
47 45 not 46
48 clinical trial.pt.
49 exp Clinical Trials as Topic/
50 (clin$ adj25 trial$).ti,ab.
51 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab.
52 placebos/
53 placebo$.ti,ab.
54 random$.ti,ab.
55 research design/
56 or/48-55
57 56 not 46
58 57 or 47
59 38 and 58
60 (2006$ or 2007$ or 2008$).ed.
61 59 and 60
EMBASE (Ovid)
1 exp Heart Failure/
2 heart failure.tw.
3 cardiac failure.tw.
4 or/1-3
5 exp Telemedicine/
6 exp Telecommunications/
7 Case Management/
8 disease management/
9 telemed$.tw.
10 telecare$.tw.
11 telecardiol$.tw.
12 telemonitor$.tw.
13 teleconsult$.tw.
14 teleconferenc$.tw.
15 telecommunicat$.tw.
16 telephon$.tw.
17 telehealth$.tw.
18 telemetry.tw.
19 (remote$ adj3 consult$).tw.
20 tele-med$.tw.
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21 tele-consult$.tw.
22 tele-conferenc$.tw.
23 tele-health$.tw.
24 Home Care/
25 Home Monitoring/
26 disease management.tw.
27 Nurse Practitioners/
28 nurse led.tw.
29 Ambulatory Monitoring/
30 telehome.tw.
31 tele-home.tw.
32 phone$.tw.
33 Patient Care Planning/
34 or/5-33
35 4 and 34
36 controlled clinical trial/
37 random$.tw.
38 randomized controlled trial/
39 follow-up.tw.
40 double blind procedure/
41 placebo$.tw.
42 placebo/
43 factorial$.ti,ab.
44 (crossover$ or cross-over$).ti,ab.
45 (double$ adj blind$).ti,ab.
46 (singl$ adj blind$).ti,ab.
47 assign$.ti,ab.
48 allocat$.ti,ab.
49 volunteer$.ti,ab.
50 Crossover Procedure/
51 Single Blind Procedure/
52 or/36-51
53 52 and 35
54 (2006$ or 2007$ or 2008$).em.
55 53 and 54
CINHAL (Ovid)
1 cardiac output, decreased/ or heart failure, congestive/ or dyspnea, paroxysmal/ or ventricular dysfunction/ or ventricular dysfunction,
left/ or ventricular dysfunction, right/
2 (heart adj failure).tw.
3 (cardiac adj failure).tw.
4 1 or 3 or 2
5 (home adj care).tw.
6 (patient adj care).tw.
7 patient care/ or case management/ or “continuity of patient care”/ or discharge planning/ or disease management/ or multidisciplinary
care team/ or nursing care/ or nursing care delivery systems/ or differentiated nursing practice/ or functional nursing/ or modular
nursing/ or primary nursing/ or progressive patient care/ or team nursing/ or total patient care nursing/ or nursing care studies/ or
nursing intensity/ or nursing process/ or nursing assessment/ or nursing care plans/ or nursing diagnosis/ or nursing interventions/ or
nursing outcomes/ or nursing protocols/ or nursing care plans, computerized/ or nursing skills/ or patient care conferences/ or clinical
conferences/ or patient-family conferences/ or primary health care/ or “quality of health care”/ or accountability/ or guideline adherence/
or “outcomes (health care)”/ or medical futility/ or outcome assessment/ or “outcomes of prematurity”/ or treatment outcomes/ or fatal
outcome/ or treatment failure/ or practice guidelines/
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8 (manag* adj care).tw.
9 managed care programs/ or health maintenance organizations/ or independent practice associations/ or preferred provider organiza-
tions/ or provider-sponsored organizations/
10 health maintenance organizations/ or medical practice/ or nursing practice/ or advanced nursing practice/ or nursing practice,
evidence-based/ or nursing practice, research-based/ or nursing practice, theory-based/ or “scope of nursing practice”/ or occupational
therapy practice/ or prescribing patterns/ or prescriptive authority/ or professional practice, evidence-based/ or medical practice,
evidence-based/ or exp nursing practice, evidence-based/ or occupational therapy practice, evidence-based/ or physical therapy practice,
evidence-based/ or exp professional practice, research-based/ or exp professional practice, theory-based/
11 (home adj care).tw.
12 home health care/ or home apnea monitoring/ or home intravenous therapy/ or home nursing, professional/
13 home care.mp. [mp=title, subject heading word, abstract, instrumentation]
14 patient care/ or after care/ or cardiovascular care/ or home nursing/ or nursing care/ or self care/ or self administration/ or self
medication/
15 (home adj intervention*).tw.
16 (secondary adj prevent*).tw.
17 (disease adj management).tw.
18 homecare.tw.
19 rehabilitat*.tw.
20 rehabilitation/ or rehabilitation, cardiac/ or conditioning, cardiopulmonary/ or rehabilitation, community-based/
21 community health nursing/ or home nursing, professional/ or rehabilitation nursing/ or rural health nursing/
22 nurs*.tw.
23 nurses/ or advanced practice nurses/ or clinical nurse specialists/ or nurse practitioners/ or case managers/
24 multidisciplin*.tw.
25 (discharge adj plan*).tw.
26 patient discharge/ or discharge planning/ or early patient discharge/ or patient discharge education/ or transfer, discharge/
27 or/5-26
28 27 and 4
29 telecommunications/ or interactive voice response systems/ or telecommuting/ or teleconferencing/ or telefacsimile/ or telehealth/
or telemedicine/ or remote consultation/ or telepathology/ or teleradiology/ or telenursing/ or telepsychiatry/ or telephone/ or wireless
communications/
30 telecommunicat*.tw.
31 (tele adj communicat*).tw.
32 telemed*.tw.
33 (tele adj med*).tw.
34 telecar*.tw.
35 (tele adj car*).tw.
36 telemonitor*.tw.
37 (tele adj monitor*).tw.
38 teleconsult*.tw.
39 (tele adj consult*).tw.
40 teleconferenc*.tw.
41 (tele adj conferenc*).tw.
42 telehealth*.tw.
43 (tele adj health*).tw.
44 telephon*.tw.
45 telemetr*.tw.
46 (tele adj metr*).tw.
47 (remote adj consult*).tw.
48 phon*.tw.
49 (electronic* adj communicat*).tw.
50 (tele adj nurs*).tw.
51 telehealth/ or telemedicine/ or remote consultation/ or telenursing/
52 or/29-51
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53 52 and 28
54 Experimental Studies/
55 exp Clinical trials/
56 ((control* or clinic* or prospectiv*) adj5 (trial* or study or studies)).tw.
57 ((allocat* or assign* or divid*) adj5 (condition* or experiment* or treatment* or control* or group*)).tw.
58 ((singl* or doubl*) adj (blind* or mask*)).tw.
59 cross?over*.tw.
60 placebo*.tw.
61 exp Clinical research/
62 Comparative studies/
63 exp Evaluation research/
64 exp “control (research)”/
65 Random assignment/
66 exp Prospective studies/
67 exp Evaluation research/
68 random*.tw.
69 RCT.tw.
70 (compar* adj5 (trial* or study* or studies)).tw.
71 or/54-70
72 53 and 71
77 limit 72 to yr=“2006 - 2008”
AMED (Allied and Complementary Medicine)
1 exp Heart Failure Congestive/
2 heart failure.tw.
3 cardiac failure.tw.
4 or/1-3
5 exp Telecommunications/
6 exp Comprehensive Health Care/
7 disease management/
8 telemed$.tw.
9 telecare$.tw.
10 telecardiol$.tw.
11 telemonitor$.tw.
12 teleconsult$.tw.
13 teleconferenc$.tw.
14 telecommunicat$.tw.
15 telephon$.tw.
16 telehealth$.tw.
17 telemetry.tw.
18 (remote$ adj3 consult$).tw.
19 tele-med$.tw.
20 tele-consult$.tw.
21 tele-conferenc$.tw.
22 tele-health$.tw.
23 Home Care Services/
24 disease management.tw.
25 nurse led.tw.
26 telehome.tw.
27 tele-home.tw.
28 phone$.tw.
29 Clinical Protocols/
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30 exp patient care management/
31 nurses/
32 “Rural health services”/
33 community health nursing/
34 or/5-33
35 4 and 34
36 (2006$ or 2007$ or 2008$).up.
37 35 and 36
Science Citations Index and Conference Citations Index on ISI Web of Knowledge
# 11 #9 and #10
Databases=SCI-EXPANDED, CPCI-S Timespan=2006-2008
# 10 ts=(random* or (clinical same trial) or rct or groups or (clinical same study)) and ts=(“heart failure” or “cardiac failure”)
# 9 #1 and #8
# 8 #2 or #3 or #4 or #5 or #6 or #7
# 7 ts=(“case management”)
# 6 ts=(“home care”)
# 5 ts=(“disease management”)
# 4 ts=((nurse same led) or (nurse same practitioner*) or (nurse same clinician*))
# 3 ts=(remote* same consult*)
# 2 ts=(tele* or phone* )
# 1 ts=(“heart failure” or “cardiac failure”)
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Since our protocol was published we decided to limit the studies included to randomised controlled trials only, we also decided to limit
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